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ABSTRACT
MINIBRAIN AND WINGS APART CONTROL ORGAN GROWTH AND TISSUE
PATTERNING THROUGH DOWNREGULATION OF CAPICUA

December 2016
Liu Yang, B.A., Northwest University, Xi’an
M.S., Northwest University, Xi’an
Ph.D., University of Massachusetts Boston
Directed by Associate Professor Alexey Veraksa
The regulation of organ growth is a fundamental aspect of developmental biology.
My work uses Drosophila as a model system to understand how the various growth
regulators are coordinated. The transcriptional repressor Capicua (Cic) controls tissue
patterning and restricts organ growth, and has been recently implicated in several cancers
and neurodegenerative diseases. Cic has emerged as a primary sensor of signaling
downstream of the receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase
(ERK) pathway, but how Cic activity is regulated in different cellular contexts remains
poorly understood. In order to identify Cic regulators, I have used affinity
purification/mass spectrometry (AP-MS) to study the Cic protein interactome
in Drosophila S2 cells and embryos. I have found that the kinase Minibrain (Mnb,
Drosophila ortholog of Down syndrome kinase DYRK1A), acting through the adaptor
iv

protein Wings apart (Wap), physically interacts with and phosphorylates the Cic protein.
Mnb and Wap inhibit Cic function by limiting its transcriptional repressor activity.
Downregulation of Cic by Mnb/Wap is necessary for promoting the growth of multiple
organs, including the wings, eyes, and the brain, and for proper tissue patterning in the
wing. This work has uncovered a previously unknown mechanism of downregulation of
Cic activity by Mnb and Wap, which operates independently from the ERK-mediated
control of Cic. Therefore, Cic functions as an integrator of upstream signals that are
essential for tissue patterning and organ growth. Finally, since DYRK1A and CIC
exhibit, respectively, pro-oncogenic versus tumor suppressor activities in human
oligodendroglioma, my results raise the possibility that DYRK1A may also downregulate
CIC in human cells.
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CHAPTER 1
INTRODUCTION

Dysregulation of organ growth results in many human diseases, such as cancers
and neurodevelopmental disorders. Understanding how organ size is controlled is a
critical and fundamental question in biological research.
Although both intrinsic and extrinsic factors contribute to the regulation of organ
growth, our understanding of this question remains incomplete. Organ size is determined
by nutritional sources in the environment. For example, nutritional deprivation at the
larval stage in Drosophila leads to small, but well-proportioned adults, suggesting an
organ-extrinsic mechanism. However, organ growth is not only controlled by nutritional
status, but also regulated by many extracellular mitogens, such as insulin, insulin-like
growth factors (IGF), epidermal growth factors (EGF) and growth hormones. These
extracellular molecules initiate a variety of intracellular signaling events to activate cell
growth, DNA replication and cell cycle progression (Lloyd, 2013).
Moreover, there must be homeostatic size-control mechanisms in which the organ
knows when to stop growing at the appropriate size. These autonomous mechanisms have
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been demonstrated in both developmental and regenerative experiments. For example,
when the wing imaginal discs from a mid-third instar larvae were transplanted into an
adult abdomen, they developed properly and stopped growth at approximately the same
size as normal wildtype discs (Bryant and Levinson, 1985). In mammals, the thyroid and
the liver retain the potential to regenerate to their full size after removal of part of their
mass in adult (Bryant and Simpson, 1984).
In general, organ growth is a consequence of cell proliferation, cell growth and
cell death. The overall growth must be coordinated at the level of individual cells. There
are several conserved signaling pathways that regulate cell growth, including the Hippo
pathway (Xu et al., 1995), the receptor tyrosine kinase (RTK) pathway (Prober and
Edgar, 2000), the mechanistic target of rapamycin (mTOR) pathway (Laplante and
Sabatini, 2012), the transforming growth factor β (TGFβ) pathway (Massague et al.,
2000), and the insulin/IGF signaling pathway (Oldham and Hafen, 2003). In this section,
I will focus on the receptor tyrosine kinase (RTK) pathway and the Hippo pathway that
were implicated in organ growth control in Drosophila.

1.1 Drosophila as a model system
The fruit fly, Drosophila melanogaster, was first introduced in the biology
laboratory by Charles W. Woodworth at Harvard University in the early 1900s, and
further used by Thomas Hunt Morgan in his genetic studies of inheritance at Columbia
University (Markow, 2015). In March 1910, Morgan discovered the very first Drosophila
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mutation, speck. Two months later, he discovered the famous white1 allele in one of his
wildtype red-eyed fly bottles (Markow, 2015). Since then, Drosophila has been used
widely as a powerful genetic system. In recent decades, Drosophila has emerged as an
ideal model organism to study organ growth. This is largely due to the studies carried out
in Drosophila imaginal discs.

The Drosophila imaginal discs
The Drosophila imaginal discs are larval epithelial tissues for forming adult
epidermal organs including the wings and eyes. They are folded pouches that are
comprised of single-layer epithelia. During the first few days of larval life, they grow
dramatically in mass but remain undifferentiated until metamorphosis (Postlethwait and
Schneiderman, 1973). This feature makes them an attractive model system to study
growth regulation. Moreover, many of the known genes that have been implicated in the
regulation of organ growth have homologues in mammals, suggesting conserved growth
control mechanisms. For example, the core components of the Hippo pathway in
Drosophila such as Hippo, Yorkie, and Warts have homologs in mammals. In addition, a
tremendous amount of genetic techniques are available in Drosophila to modulate gene
expression during the imaginal discs development. For instance, mitotic recombination
clones lacking specific genes can be generated in imaginal discs using the FRT/Flp
technique (Theodosiou and Xu, 1998). Similarly, particular genes can also be
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overexpressed or downregulated in mitotic clones using the CoinFLP method (Bosch et
al., 2015), or in specific regions by using the GAL4 system (Brand and Perrimon, 1993).
The Drosophila wing imaginal disc is likely the most extensively studied model
for growth control. Most of our understanding of organ growth control has been derived
from the studies of the wing imaginal discs. The Drosophila wing imaginal disc derives
from a cluster of approximately 30 cells that invaginate from the embryonic epithelium
(Hariharan, 2015). These cells undergo 9-11 rounds of cell division and grow to a cluster
of 30,000-50,000 cells at the end of the larval stage (Hariharan, 2015; Martin et al., 2009;
Worley et al., 2013). The arrangement of the Drosophila wing imaginal discs (Fig. 1.1) is

Figure 1.1. Schematic of the Drosophila wing imaginal disc. The boundary between anterior
(A) and posterior (P) compartments is shown as a blue line, and the boundary between
ventral (V) and dorsal (D) is shown as a dotted red line.
4

subdivided into anterior and posterior compartments, and then into dorsal and ventral
compartments at the second-instar larval stage (Irvine and Harvey, 2015). The wing discs
from late third-instar larvae consist of two apposed sheets: the thick folded disc
epithelium and the thin peripodial membrane. During the prepupal and pupal
development, the disc epithelium folds back to form the apposed dorsal and ventral
compartments of the wing blade (Fig. 1.1).

Figure 1.2. The wildtype Drosophila adult wing. The locations of the longitudinal
veins (L1-L5) and the incomplete vein (L6) are indicated. The crossveins are
indicated as ACV and PCV. The boundary between anterior (A) and posterior (P)
compartments are shown as a blue line.
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The vein pattern of the Drosophila adult wing.
In the Drosophila wing, there are five longitudinal veins (L1-L5) which span the
wing proximodistally. There are also two crossveins, the anterior and posterior crossveins
(ACV and PCV), which connect the longitudinal L3-L4 and L4-L5, respectively (Fig.
1.2). In addition, there is an incomplete longitudinal vein, L6, in the posterior
compartment. The adult wing consists of two apposed surfaces, dorsal and ventral.
Therefore, the veins are sometimes referred to as dorsal or ventral veins. The adult wing
veins can be traced back to their primordia in the wing discs.

1.2 The Hippo signaling pathway
In the past two decades, it has been established that the Hippo signaling pathway
functions as a key regulator in organ size control (Hariharan, 2015; Irvine and Harvey,
2015). In 1995, the Hippo signaling pathway was first discovered in mosaic genetic
screens for Drosophila tumor suppressor genes. Loss-of-function alleles of warts (wts)
result in an overgrowth of multiple tissues, which include the eyes, wings, legs, and the
central nervous system (Justice et al., 1995; Xu et al., 1995). Subsequently, a flurry of
studies identified additional key pathway regulators, including the WW domaincontaining protein Salvador (Sav) (Kango-Singh et al., 2002; Tapon et al., 2002), the
Ste20-like protein kinase Hippo (Hpo) (Harvey et al., 2003; Pantalacci et al., 2003; Udan
et al., 2003; Wu et al., 2003), and the adaptor Mob as tumor suppressor (Mats) (Lai et al.,
2005). Lost-of-function mutants for any of these four proteins phenocopy tissue
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overgrowth in Drosophila caused by wts alles. In 2005, the transcriptional coactivator
Yorkie (Yki) was identified as a component of the Hippo pathway in a yeast two-hybrid
screen for Wts-interacting proteins (Huang et al., 2005). Thus, these five proteins (Wts,
Hpo, Sav, Mats and Yki) form the core of the Hippo signaling pathway.
The Hippo pathway is evolutionarily conserved from Drosophila to humans. The
core five members of the Hippo pathway have direct mammalian orthologs. They have
conserved roles in growth control, differentiation and morphogenesis. Recently, more
than 40 proteins have been implicated in both Drosophila and mammalian Hippo
pathway (Irvine and Harvey, 2015; Pan, 2010). These Hippo pathway components can be
subdivided into three groups: the core kinase cassette, the upstream regulatory proteins
and the downstream transcriptional regulatory proteins (Irvine and Harvey, 2015).

The core kinase cassette of the Hippo pathway
The core kinase cassette proteins include Hpo, Wts, Sav, Mats and Yki, of which
Hpo and Wts function as kinases. Sav serves as a scaffold protein for the phosphorylation
and activation of Wts by Hpo. Similarly, Yki is phosphorylated by Wts and its adaptor,
Mats. Yki is the key effector of the Hippo pathway, and functions as a transcriptional
coactivator. In Drosophila, Yki requires another transcriptional co-activator, Scalloped
(Sd), to regulate gene expression, which facilitates tissue growth (Goulev et al., 2008;
Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2008b). Yki functions downstream of
Hpo, Sav, and Wts since epistasis experiments have shown that depletion of Yki
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suppresses the overgrowth phenotype associated with Hpo, Sav and Wts mutants,
whereas overexpression of Yki phenocopies the Hpo, Sav and Wts mutants (Huang et al.,
2005). Yki functions as an oncogene and promotes the transcription of genes controlling
cell proliferation and the inhibition of apoptosis. When Yki is present in the nucleus, it
can activate a variety of factors that promote tissue growth. Activation of Hippo signaling
results in the phosphorylation and inactivation of Yki by Wts, followed by nuclear export
and cytoplasmic accumulation (Oh and Irvine, 2008; Pan, 2010; Yu and Guan, 2013).
Recently, Misshapen (Msn) has been identified as another kinase that phosphorylates
Wts, which negatively regulates the Yki activity (Li et al., 2014).

The downstream transcriptional regulatory proteins of the Hippo pathway
The Yki target genes can be classified into three groups (Pan, 2010). The first
class of genes includes the cell-autonomous growth promoting targets of Yki, such as the
microRNA bantam, Myc, CyclinE, E2F1, and the apoptosis inhibitor diap1 (Goulev et al.,
2008; Nolo et al., 2006; Thompson and Cohen, 2006; Wu et al., 2003). The second class
of Yki targets includes Kibra, Merlin (Mer), Expanded (Ex) and Four-jointed (Fj), as Yki
upregulates their expression. Interestingly, Kibra, Mer and Ex can serve as upstream
signals for the Hippo pathway, suggesting a negative feedback mechanism (Cho et al.,
2006; Genevet et al., 2010; Hamaratoglu et al., 2006; Yu et al., 2010). The third class of
Yki targets contains signaling molecules that are also implicated in pathway crosstalk.
These proteins include the Notch ligand Serrate, the EGFR ligand Vein, Wingless, E-
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Cadherin, and Dally and Dally-like (Baena-Lopez et al., 2008; Cho et al., 2006; Genevet
et al., 2009; Zhang et al., 2009).

The upstream regulatory proteins of the Hippo pathway
Unlike ligand-receptor driven signaling pathways, the upstream signals for the
Hippo pathway are not yet fully understood. It has been shown that the Hippo signaling
pathway is regulated by cell polarity, cell adhesion, the actin cytoskeleton, cell contact
and mechanical force (Sun and Irvine, 2016).
Three cell-cortex localized proteins, Kibra, Mer and Ex, were reported as scaffold
proteins for the core kinase cassette to activate the Hippo pathway, as their loss-offunction mutants have similar tissue overgrowth phenotype. In contrast, overexpression
of Kibra, Mer and Ex was found to promote the activity of Hpo and Wts (Baumgartner et
al., 2010; Genevet et al., 2010; Yu et al., 2010). Additionally, Kibra, Mer and Ex might
activate the Hippo pathway through the Tao-1 kinase, which phosphorylates and activates
Hpo (Boggiano et al., 2011; Poon et al., 2011).
Cell adhesion and cell polarity proteins can also regulate Hippo signaling. For
example, the cell adhesion protein, Echinoid (Ed) was found to function as a tumor
suppressor since it binds to and stabilizes Sav, which activates Hpo (Yue et al., 2012). In
addition, many proteins that regulate apicobasal polarity of the epithelial cells have been
implicated in controlling the Hippo pathway activity. These proteins include Lethal giant

9

larvae (Lgl), Scribble (Scrib), Discs Large (Dlg) and Crumbs (Crb) (Chen et al., 2010;
Ling et al., 2010; Robinson et al., 2010; Zhao et al., 2008a).
The Hippo pathway is also controlled by the actin cytoskeleton. Modulating the
expression of actin regulators, including capping proteins and Diaphanous, can affect Yki
activity and tissue growth (Fernandez et al., 2011; Sansores-Garcia et al., 2011). In
Drosophila wing disc, increased cytoskeletal tension can suppress Yki activity by
inducing the apical localization of Ajuba/LIM protein Jub, which is a negative regulator
of Warts (Rauskolb et al., 2014). Recently, it has been shown that disruption of the
Spectrin proteins network leads to tissue overgrowth by activating Yki-mediated gene
expression (Deng et al., 2015; Fletcher et al., 2015).
In addition, the atypical cadherins, Fat (Ft) and Dachsous (Ds), play important
roles in regulating the Hippo pathway (Bennett and Harvey, 2006; Matakatsu and Blair,
2006). Ds and Ft function as a ligand-receptor pair to affect the localization of each other
(Ma et al., 2003). The interaction between Ft and Ds is mediated by the kinase Fj, as it
phosphorylates Ft and Ds on their extracellular regions (Ishikawa et al., 2008). Ft and Ds
can affect the subcellular localization of the atypical myosin, Dachs, and thereby
influence the protein level and/or cellular distribution of Wts and Ex (Bennett and
Harvey, 2006; Cho et al., 2006; Silva et al., 2006; Willecke et al., 2006). This mechanism
is likely independent of Wts phosphorylation by Hpo. More recently, it has been shown
that the Wts activity is regulated by an allosteric mechanism, in which a Drosophila
Mps1 one binder (Mob) protein, Mats, converts Wts from an inactive to active state. This
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transition can be inhibited or reversed by Ft and Ds signaling via Dachs (Vrabioiu and
Struhl, 2015).
We and our collaborators have identified another downstream branch of Ft and Ds
signaling that regulates the Hippo signaling (Degoutin et al., 2013). In this study, we
identified the WD40 repeat protein, Wings apart (Wap), also known as Riquiqui, as a Dsinteracting protein. Wap functions together with the Minibrain kinase (Mnb) to interact
with and phosphorylate Wts, which in turn inhibits Wts-mediated phosphorylation of
Yki, resulting in Yki derepression. This branch of signaling downstream of Ds regulates
Wts and Yki independently of Dachs (Degoutin et al., 2013).

The Mnb Kinase
In addition to its role in Hippo signaling, Mnb and its mammalian homolog,
DYRK1A, functions as key regulator of neuronal development. The role of Mnb in
neurodevelopment was first elucidated by the analysis of mnb mutants of Drosophila
(Tejedor et al., 1995). The mnb mutant alleles display a remarkable reduction in the size
of the adult brain, particularly in the optic lobes (OL). However, the overall neuronal
architecture is preserved. The reduction in the size of the central brain occurs mainly in
the dorsal-ventral (DV) and anterior-posterior (AP) directions (Tejedor et al., 1995).
However, the sizes of other organs, such as the body and sensory organs, appear almost
indistinguishable from wildtype. This neuronal specific phenotype is caused by altered
proliferation in the neuroepithelial primordia of the larval CNS, as axon bundles between
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the lobula complex and the optic stalk are thinner, and the anterior optic tract fibers and
cervical connective fibers are reduced. In addition, the mutant animals display behavioral
abnormalities, such as reduced locomotor activity and impaired odor discrimination
(Tejedor et al., 1995).
In Drosophila embryos, Mnb proteins are expressed predominately in the central
nervous system (CNS) (Tejedor et al., 1995). Drosophila embryos and pupae contain
more Mnb proteins than adults. In late embryos, Mnb is expressed in the supraesophageal
ganglion and the ventral nerve cord, but is absent in the peripheral nervous system. In
third instar larval brain, Mnb is expressed prominently in the mushroom body neuropil
and OL. However, Mnb expression is relatively low in the adult OL and central brain
(CB), suggesting that Mnb is critical for the development of the OL and CB, but not for
the maintenance of neurons in these structures (Tejedor et al., 1995). More recently, Mnb
has been found to be expressed in a subset of symmetrically located neurons, posterior to
the antennal lobe in the adult brain (Hong et al., 2012).
Mnb is an evolutionarily conserved kinase. Its mammalian ortholog, DYRK1A,
plays critical roles in neurogenesis, proliferation, neuronal differentiation, survival,
apoptosis and synaptic plasticity. DYRK1A belongs to the dual-specificity tyrosine–
regulated kinase (DYRK) family. The human DYRK1A gene is located on chromosome
21 (Guimera et al., 1997). DYRK1A in trisomy produces multiple cognitive deficits
associated with Down syndrome (DS) (Becker et al., 2014; Duchon and Herault, 2016;
Hammerle et al., 2003; Smith et al., 1997). In addition, elevated DYRK1A activation has
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been implicated in Alzheimer’s disease and Pick disease (Ferrer et al., 2005; Kimura et
al., 2007). Recently, DYRK1A has been associated with autism spectrum disorders
(ASDs) (O'Roak et al., 2014; Willsey and State, 2015).
DYRK1A is a dose-sensitive gene, as both overexpression and reduction of
DYRK1A protein in transgenic mice results in growth defects and DS related
phenotypes, including locomotor activity, coordination, and cognition defects (Altafaj et
al., 2001; Arque et al., 2008; Benavides-Piccione et al., 2005; Branchi et al., 2004;
Dierssen, 2013; Dierssen and de Lagran, 2006; Ferrer et al., 2005; Fotaki et al., 2002;
Fotaki et al., 2004; Martinez de Lagran et al., 2004). Homozygous null DYRK1A
mutation causes lethality in the mouse in utero and results in delayed general growth and
size reductions in multiple organs including the developing brain in the embryo. Mice
heterozygous for the DYRK1A allele survive to adulthood, but display decreased neonatal
viability and reduction in brain size, as well as behavioral defects (Fotaki et al., 2002;
Fotaki et al., 2004). Moreover, patients with heterozygous mutations in DYRK1A exhibit
developmental delays and mental retardation associated with microcephaly, seizures,
facial dysmorphisms and cardiac hypertrophy (Bronicki et al., 2015; Fernandez-Martinez
et al., 2015; Ruaud et al., 2015; van Bon et al., 2016). Disruptive or loss-of-function
mutations of DYRK1A have been implicated in many neurodevelopmental disorders,
including autosomal dominant mental retardation 7 (MRD7), autism spectrum disorder
(ASD) and intellectual disability (ID) (Bronicki et al., 2015; Duchon and Herault, 2016;
Moller et al., 2008; van Bon et al., 2016).
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The overexpression of DYRK1A in mouse models is sufficient to induce
phenotypes similar to DS patients (Dierssen and de Lagran, 2006; Dierssen et al., 2006;
Dierssen et al., 2009; Guedj et al., 2012). In contrast, reducing the expression of
DYRK1A in DS mouse models by shRNA injection results in a persistent increase in
synaptic strength, reduced motor alteration and restored memory performance (Altafaj et
al., 2013; Ortiz-Abalia et al., 2008). As a result, DYRK1A inhibitors, such as harmine
and epigallocatechin-3-gallate (EGCG), have been developed for the treatment of DS
(Bain et al., 2003; De la Torre et al., 2014; Gockler et al., 2009; Laguna et al., 2008; Noll
et al., 2012).

1.3 The receptor tyrosine kinase (RTK) pathway
The receptor tyrosine kinase (RTK) pathway is a critical pathway that regulates
growth and survival since the RTK receptors mediate the transduction of proliferation
signal from growth factors, including EGF, Platelet-derived growth factor (PDGF),
fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF) and
hepatocyte growth factor (HGF) (Lemmon and Schlessinger, 2010). It is well known that
the RTK pathway serves not only as a critical regulator of normal cellular responses, but
also as a key element in development and progression of human cancers (Kratchmarova
et al., 2005; Meloche and Pouyssegur, 2007). Dysregulation of RTK pathways is
frequently implicated in human cancers and hyper-proliferative diseases (Dhillon et al.,
2007).
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Overview of RTK signaling
The receptor tyrosine kinase (RTK) signaling pathway has been intensively
studied for the past three decades. It controls numerous critical cellular responses, which
include proliferation, differentiation, development, metabolism, cell migration and cell
survival (Dhillon et al., 2007; Lemmon and Schlessinger, 2010; Marshall, 1995; Simon,
2000). The key regulatory mechanisms of RTK signaling are highly conserved from C.
elegans to humans. Dysregulation of the RTK pathway leads to numerous human
diseases, such as cancers, diabetes and inflammation. In addition, cancer driver
mutations are frequently found in RTK pathway components (Cai et al., 2013; Li and
Hristova, 2006; Robertson et al., 2000).
Human RTKs include 20 subfamilies of proteins with similar overall structures:
they contain a single transmembrane domain that separates the extracellular region from
the intracellular tyrosine kinase region. Typically, binding of the extracellular ligands to
the cell surface RTK receptors induces conformation change and RTK dimerization,
which leads to RTK autophosphorylation on tyrosine residues as well as a series of
phosphorylations on other signaling molecules. This in turn initiates a number of
intracellular signaling cascades including the mitogen-activated protein kinase (MAPK)
pathway, the phosphatidyl-inositol-3-kinase (PI3K) pathway and phospholipase Cγ
(PLCγ) pathways (Lemmon and Schlessinger, 2010). The most well characterized
pathway downstream of RTKs is the MAPK pathway.
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Most RTKs activate the small GTPase Ras, which stimulates the MAPK cascade
by a series of phosphorylation events (Schlessinger, 2000). The sequential activation of
the MAPK cascade includes activation of Raf (MAPKKK), MEK (MAPKK) and
ultimately ERK (MAPK), and is a conserved mechanism. Activated MAPK
phosphorylates more than 200 substrates in the cytoplasm, nucleus and cell membrane
(Futran et al., 2015). Previous studies showed that Ets-domain transcription factors are
key effectors of RTK signaling (Hollenhorst et al., 2011; Jacobs et al., 1998; Murphy et
al., 2002). For example, two ETS factors, Pointed-P2 and Yan, are thought to be
downstream effectors of all RTKs in Drosophila (Rebay and Rubin, 1995). Pointed-P2
and Yan are both direct targets of MAPK in response to RTK signaling. MAPK
dependent phosphorylation activates Pointed-P2, which serves as a transcriptional
activator to activate the downstream target genes that are required for eye development.
Conversely, Yan functions as a transcriptional repressor, which is inhibited by MAPK
dependent phosphorylation. Phosphorylated Yan is exported from the nucleus to the
cytoplasm for degradation, which leads to the expression of the RTK target genes
(Brunner et al., 1994; Gabay et al., 1996; Rebay and Rubin, 1995; Schlessinger, 2000).

The RTK pathway and growth control
Considerable evidence suggests that the activation of the RTK pathway is
required for organ growth. Loss-of-function mutations in the core components of the
RTK pathway result in many growth defects in Drosophila. For example, raf mutant
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larvae lack imaginal discs except the underdeveloped eye imaginal discs, and reduction
of organ size is also observed in brain lobes, lymph glands, testes and ovaries (Nishida et
al., 1988). rl (ERK) null mutation leads to larval lethality and a significant reduction in
the size of imaginal discs (Biggs et al., 1994). Moreover, mitotic clones expressing a
dominant negative form of Ras exhibit decreased cell and clone sizes, whereas gain-offunction mutations in Ras result in increased cell and clone sizes (Prober and Edgar,
2000).
In humans, it has been shown that the deregulation of the RTK pathway can lead
to increased signaling activity. This results in a variety of diseases including cancers. For
example, gene amplification and overexpression of HER2 is implicated in a variety of
human cancers, particularly in human breast and ovarian cancer (Slamon et al., 2001). In
addition, the overexpression of EGFR is frequently found in squamous-cell carcinomas of
the head and neck in non-small-cell lung, kidney, pancreatic, ovarian, cervical, and
bladder cancer (Rocha-Lima et al., 2007). Furthermore, the aberrations in RTK activation
have been implicated in other hyperproliferative diseases such as psoriasis (Zwick et al.,
2002). However, the mechanisms how RTK pathway regulates growth are not well
understood.
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Figure 1.3. Schematic of RTK-dependent Control of gene expression by Cic.

1.4 The Capicua transcriptional repressor
Recently, the High Mobility Group (HMG)-box protein Capicua (Cic) has been
identified as a general downstream sensor of RTK activation (Jimenez et al., 2000). Cic
was first identified as a repressor of RTK Torso target genes, which control the
development of the terminal regions of the embryo. Therefore, it was named “Capicua”,
which means “head and tail” in Catalan (Jimenez et al., 2000). It was demonstrated that
Cic mediates the expression of multiple RTK target genes downstream of Torso and the
epidermal growth factor receptor (EGFR) pathways (Ajuria et al., 2011; Goff et al., 2001;
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Jimenez et al., 2000; Jimenez et al., 2012; Roch et al., 2002). As shown in Fig. 1.3, in the
absence of RTK activation, Cic represses the transcription of RTK target genes. When
RTK signaling is activated, active MAPK (ERK) phosphorylates Cic, which relieves the
Cic-mediated repression of RTK target genes.
Cic is conserved from worms to mammals. Three conserved domains have been
identified in the Cic proteins. One is the HMG box region which is responsible for
recognition and binding to the octameric T(G/C)AATG(A/G)A DNA sites in target genes
(Ajuria et al., 2011). The other motif that has a repressor function, C1, is located at the
carboxy-terminal end of the Cic protein (Astigarraga et al., 2007; Jimenez et al., 2000).
The third motif is amino-terminal to the HMG-box and includes a binding interface for
the Ataxin-1 (ATXN1) protein. The Drosophila Cic protein also contains the C2 domain
which was identified as the MAPK-docking motif (Astigarraga et al., 2007). There are
two main CIC isoforms (CIC-L and CIC-S) expressed in Drosophila (Fig. 1.4). Cic-S
has been intensively studied in recent years while little is known about the aminoterminal extension in Cic-L (Jimenez et al., 2012).

Figure 1.4. Schematic of the two main isoforms of Cic proteins in Drosophila.

19

MAPK-dependent regulation of Cic
MAPK dependent phosphorylation of Cic is a well-characterized mechanism in
Drosophila. For example, RTK Torso activation induces the phosphorylation of the
Drosophila MAPK ERK homologue, Rolled (Rl), in the pole regions of the early embryo.
Activated MAPK phosphorylates and downregulates Cic in the same regions (Coppey et
al., 2008; Jimenez et al., 2000). This phosphorylation is dependent on the interaction
between the Cic C2 motif and Rl since mutations in the Cic C2 motif are insensitive to
Torso or EGFR inactivation. The resulting phenotype is similar to the effects of Torso or
EGFR loss-of-function (Astigarraga et al., 2007). Torso signaling not only induces Cic
phosphorylation but also reduces the Cic protein level. For example, activation of Ras in
the wing imaginal disc results in reduction of Cic levels (Roch et al., 2002).
Phosphorylation of Cic also changes the rate of its nucleocytoplasmic shuttling (Grimm
et al., 2012). A recent study showed that MAPK dependent relief of Cic repression is a
two-tier process: phosphorylated Cic rapidly loses its repressor activity which is followed
by a slower export from the nucleus, ultimately resulting in the reduction of protein level
(Lim et al., 2013).
Studies in mammalian cells also provide evidence for RTK/MAPK dependent
phosphorylation of Cic, which indicates that this is a conserved mechanism. A global
phosphoproteomic analysis in HeLa cells revealed that Cic becomes phosphorylated
within 10 minutes after stimulating the cells with EGF (Olsen et al., 2006). Another
study showed that EGF stimulation of HEK293T cells induces phosphorylation of Cic,
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which prevents its binding with importin α4/karyopherin α3 (KPNA3) (Dissanayake et
al., 2011). This is consistent with the Drosophila study that showed that RTK activation
affects nucleocytoplasmic shuttling of Cic (Grimm et al., 2012). In addition, the study in
HEK293T cells showed that p90 ribosome S6 kinase (p90RSK) phosphorylates Ser173 of
Cic, which promotes its interaction with 14-3-3 proteins (Dissanayake et al., 2011).

Cic and its targets in RTK signaling
Cic was first identified as a repressor of the RTK Torso target genes such as
tailless (tll) and huckebein (hkb) in Drosophila (de las Heras and Casanova, 2006;
Jimenez et al., 2000; Li, 2005). The Torso receptor is ubiquitously expressed in the
plasma membrane of the early Drosophila syncytial embryo, but its activation only
happens in the anterior and posterior poles of the embryo. This is due to the restricted
proteolytic processing of its ligand, Trunk (Trk), that only takes place at the poles of the
oocyte, producing the C terminal part of Trk as an active ligand (Furriols and Casanova,
2003). Then the Torso-Ras-MAPK pathway is activated at the poles. As a result, Cic is
downregulated in the same regions, which allows for the expression of the target genes tll
and hkb.
In addition, Cic functions as a repressor of Drosophila wing vein-specific genes
downstream of the EGFR pathway. One of these genes is argos (aos), which encodes a
secreted factor involved in negative feedback control of EGFR signaling (Freeman and
Gurdon, 2002). In wing vein cells, aos expression is autonomously repressed by Cic.
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Similarly, EGFR activation downregulates Cic level and induces the expression of aos in
vein cells, which is required for vein patterning (Ajuria et al., 2011; Blair, 2007; Roch et
al., 2002). Moreover, Cic acts in a similar way to repress the expression of the
intermediate neuroblasts defective (ind) in embryonic neuroectoderm, and mirror (mirr)
in ventral cells (Ajuria et al., 2011; Atkey et al., 2006; Roch et al., 2002).
In humans, few Cic targets have been identified. A study in HEK293T cells
reported that the RNAi depletion of Cic results in elevated mRNA levels of the PEA3
subfamily of ETS transcription factors, including ETV1, ETV4 and ETV5 (Dissanayake
et al., 2011). This finding suggests that Cic is required for transcriptional repression of
these genes, which are overexpressed in several breast and prostate cancer cases (Carver
et al., 2009; Hermans et al., 2008; Jane-Valbuena et al., 2010). This is consistent with the
study in Ewing’s sarcoma cases, as CIC-DUX4 fusions were found in both two Ewing’s
sarcoma cases and the CIC-DUX4 chimera results in a significant upregulation of
ERM/ETV5 and ETV1 genes (Kawamura-Saito et al., 2006).

Cic and EGFR signaling
The role of the EGFR-Ras-MAPK pathway in promoting proliferation of imaginal
discs is well characterized in Drosophila (Hariharan and Bilder, 2006). For example,
loss-of-function mutations in Ras/MAPK pathway components result in small imaginal
discs, whereas gain of function mutations such as RasV12 are sufficient to drive ectopic
cell proliferation and tissue growth (Karim and Rubin, 1998; Prober and Edgar, 2000).
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Considerable evidence suggests that Cic negatively regulates proliferation
downstream of the EGFR-Ras-MAPK pathway. The role of Cic as a negative regulator of
growth was first described by the Hariharan lab. Loss-of-function mutations of Cic were
shown to promote tissue growth in eye imaginal discs, which indicated that the normal
function of Cic is to inhibit cell growth (Tseng et al., 2007). In the same study, Cic
protein level was elevated in the loss-of-function clones of EGFR or Ras, whereas RasV12
clones had reduced level of Cic. In addition, loss-of-function mutations of Cic bypassed
the requirement of Ras in cell proliferation. These data support the role of Cic in
regulating proliferation downstream of EGFR-Ras-MAPK.
Moreover, Cic restricts the growth of stem cells, as studies in Drosophila showed
that RNAi depletion of Cic induced the ectopic proliferation of intestinal stem cells
(ISCs) (Jiang et al., 2011; Jin et al., 2015). The activation of EGFR pathway results in
ISC growth as well as regeneration in the midgut epithelial cells (Buchon et al., 2010;
Jiang and Edgar, 2009; Jiang et al., 2011). Cic functions downstream of the EGFR
pathway to regulate ISC proliferation (Jin et al., 2015). A genome-wide mapping of Cic
target genes in ISC has identified cell cycle genes, string (stg, Cdc25) and Cyclin E
(CycE), as RNAi depletion of Cic leads to elevated mRNA levels of these genes (Jin et
al., 2015). Cic was found to regulate the ETS family transcription factors, pnt and Ets21C
through direct binding to the TGAATGAA motif (Jin et al., 2015).
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Cic and the Hippo signaling pathway
It has been shown that Cic is regulated by the Hippo pathway. One of the Ykitarget genes is microRNA bantam. Yki activates expression of bantam microRNA, and
bantam is necessary for Yki-induced overproliferation (Thompson and Cohen, 2006).
Interestingly, it was found that bantam expression was repressed by Cic (Herranz et al.,
2012). Herranz et al. also showed that bantam is subject to regulation by the EGFR
pathway via relief of Cic repression, suggesting that bantam serves as a common target of
the EGFR and Hippo pathways. Conversely, bantam represses the expression of Cic
through a negative feedback loop mechanism. In addition, the same study showed that
Yki could activate the EGFR pathway but EGFR was not required for Yki to activate
bantam (Herranz et al., 2012). Overall, cross-regulatory relationships between the Hippo
and EGFR pathways appear to be rather complex, suggesting that there might be two
parallel signaling inputs from Yki to Cic: EGFR-dependent and bantam dependent.

Cic and neurodegeneration
Cic has been implicated in several human diseases, such as spinocerebellar ataxia
type1 (SCA1) neurodegeneration, which is caused by the expansion of the polyglutamine
region of the disease protein, Ataxin-1 (ATXN1) (Watase et al., 2002). The normal
ATXN1 protein contains up to 39 copies of glutamine, whereas the polyglutamineexpanded mutant contains 40 or more copies (Lasagna-Reeves et al., 2015).
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It has been reported that both Cic isoforms (Cic-L and Cic-S) form a native
nuclear complex with ATXN1 in the wildtype mouse cerebellum (Lim et al., 2006).
Polyglutamine-expanded ATXN1 interacts less efficiently with Cic, which indicates that
ATXN1 might function as a co-repressor and loss of repressor activity may contribute to
SCA1 neurodegeneration (Crespo-Barreto et al., 2010). This is consistent with the finding
that Cic target genes such as ETV5 are upregulated in mice expressing polyglutamineexpanded ATXN1 (Lam et al., 2006; Lim et al., 2008). However, another study reported
that polyglutamine-expanded ATXN1 promotes the binding of Cic to the promoters of
specific genes causing hyper-repression of these genes, whereas reducing the binding of
Cic to other specific genes leading to derepression effects (Fryer et al., 2011). As a result,
genetic reduction of Cic levels by 50% resulted in a partial rescue of SCA1 mouse,
improving motor functions and survival rate (Fryer et al., 2011; Zoghbi and Orr, 2009).
More recently, a study proposed that Cic does not discern between wildtype ATXN1 and
polyglutamine-expanded ATXN1. Cic interacts with wildtype ATXN1, and forms a
natural transcriptional repressor complex with ATXN1. Cic binds equally well to
polyglutamine-expanded ATXN1, but assembles and stabilizes a dysfunctional
oligomeric complex. This dysfunctional complex assembles into toxic aggregates, driving
pathogenesis (Lasagna-Reeves et al., 2015).

Cic and human tumors
Recently, mutations in CIC have been implicated as potential markers for certain
human brain tumors (Alentorn et al., 2012; Chan et al., 2014). As shown in Table 1.1,
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CIC mutations were frequently found in human brain tumor samples, especially
oligodendrogliomas (OD), which is the second most common malignant brain tumor in
adults. Most of the mutations are located in the HMG-box region, which indicates that
the mutations result in loss of CIC activity as a transcriptional repressor and suggests that
CIC may act as a tumor suppressor (Bettegowda et al., 2011). In addition, CIC-DUX4
fusion proteins resulting from chromosomal translocations were identified in Ewing-like
sarcoma cases. The CIC-DUX4 fusion functions as a transcription activator rather than a
repressor, which results in the overexpression of the downstream genes, including the
PEA3 subfamily of ETS transcription factors (Arvand and Denny, 2001; KawamuraSaito et al., 2006). Moreover, CIC mutations have been implicated in other cancers,
including breast cancer (Sjoblom et al., 2006), and colon cancer (Seshagiri et al., 2012).
More recently, a study showed that CIC negatively regulates prostate cancer progression
(Choi et al., 2015).
In summary, it is obvious that Cic plays a critical role in controlling tissue growth,
and is implicated in several neurodegenerative diseases and human cancers. There is
evidence that Cic activity is under the control of the RTK pathway as well as possibly the
Hippo pathway. However, the molecular details of how Cic activity is regulated by
signaling pathways is not well understood. My research started from a proteomic
approach to study Cic-interacting proteins, with the goal of uncovering how Cic is
regulated and how it contributes to organ growth and tissue patterning.
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Tumor Types

Positive/ Total

References

Oligodendrogliomas

6/7

(Bettegowda et al., 2011)

Oligodendrogliomas

22/47

(Chan et al., 2014)

Oligodendrogliomas

15/18

(Sahm et al., 2012)

Oligodendrogliomas

23/50

(Jiao et al., 2012)

Oligodendrogliomas

14/42

(Sahm et al., 2012)

Oligodendrogliomas

20/29

(Yip et al., 2012)

Astrocytomas

3/10

(Sahm et al., 2012)

Oligodendrogliomas

60/127

(Gleize et al., 2015)

Breast cancer

3/11

(Sjoblom et al., 2006)

Colon cancer

6/72

(Seshagiri et al., 2012)

Table 1.1 Cic mutations found in tumor samples.
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CHAPTER 2
MINIBRAIN AND WINGS APART CONTROL ORGAN GROWTH AND TISSUE
PATTERNING THROUGH DOWNREGULATION OF CAPICUA

This chapter was adapted from Yang, L., Paul, S., Trieu, K.G., Dent, L.G., Froldi, F.,
Forés, M., Webster, K., Siegfried, K.R., Kondo, S., Harvey, K., Cheng, L., Jiménez, G.,
Shvartsman, S.Y. and Veraksa, A. (2016). Minibrain and Wings apart control organ
growth and tissue patterning through down-regulation of Capicua. Proc Natl Acad Sci
USA 113(38), 10583-10588. The analysis of mnbd419 mutant phenotypes in larva and
pupal brains were performed by Dr. Francesca Froldi. Dr. Marta Forés generated the cic3
allele, recombined cic3 allele with mnbRNAi, and performed the analysis of the wing
phenotypes involving this mutation. I performed all other experiments discussed in this
chapter.

2.1 Introduction
The High Mobility Group (HMG)-box transcriptional repressor protein Capicua
(Cic) has been identified as a key regulator of tissue patterning and organ growth in
multiple developmental contexts (Jimenez et al., 2000; Jimenez et al., 2012). In
Drosophila, Cic controls anteroposterior and dorsoventral embryonic polarity, the
subdivision of the lateral ectoderm, and pattern formation in several tissues (Ajuria et al.,
2011; Astigarraga et al., 2007; Goff et al., 2001; Jimenez et al., 2000; Roch et al., 2002).
In addition, Cic negatively regulates the growth of imaginal discs and the midgut (Jin et
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al., 2015; Tseng et al., 2007). In humans, a single Cic ortholog (CIC) has been implicated
in the neurodegenerative disease spinocerebellar ataxia 1 (SCA1) (Lam et al., 2006), and
recently mutations in Cic have been found in the majority of oligodendroglioma cases,
suggesting that CIC is a tumor suppressor (Bettegowda et al., 2011; Sahm et al., 2012;
Wesseling et al., 2015).
In both Drosophila and mammals, Cic functions as a primary sensor of signaling
downstream of the receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase
(ERK) pathway (Ajuria et al., 2011; Astigarraga et al., 2007; Dissanayake et al., 2011;
Grimm et al., 2012; Jimenez et al., 2012; Jin et al., 2015; Kim et al., 2010b; Kim et al.,
2011; Tseng et al., 2007). According to the current model, activation of RTK signaling
results in the accumulation of doubly-phosphorylated activated ERK, which directly
binds to and phosphorylates Cic (Astigarraga et al., 2007). ERK-mediated Cic
phosphorylation leads to a rapid relief of repression of Cic target genes, followed by a
slower export from the nucleus and eventual cytoplasmic degradation (Grimm et al.,
2012; Lim et al., 2013). The molecular details of these processes are unknown, though
apparently each of them contributes to the overall downregulation of Cic activity. Cic is
also involved in a mutual regulatory relationship with the Hippo pathway, though
regulation of Cic in this context appears to take place at the RNA level (Herranz et al.,
2012).
In this chapter, I present the identification of the kinase Minibrain (Mnb)
(Degoutin et al., 2013; Tejedor et al., 1995) and an adaptor protein, Wings Apart (Wap)
(Degoutin et al., 2013; Morriss et al., 2013), as novel Cic regulators that cooperate to
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phosphorylate Cic and restrict its repressor activity. I show that Mnb/Wap and ERK
target different regions of the Cic protein for phosphorylation, and that inhibition of Cic
activity by Mnb and Wap is required for the growth of several organs and for correct
patterning of the wing. These data suggest that Mnb/Wap-dependent downregulation of
Cic occurs in parallel to the RTK/ERK and Hippo signaling pathways. I propose that Cic
functions as an integrator of upstream developmental signals which together tightly
control its activity. This mechanism is necessary for the proper execution of tissue
patterning and regulation of organ growth.

2.2 Results
Characterization of Cic interactomes
In order to identify Cic regulators, I used affinity purification/mass spectrometry
(AP-MS) (Veraksa, 2013) to study the Cic protein interactome in Drosophila S2 cells and
embryos (Fig. 2.1A). SBP tagged Cic protein was expressed in Drosophila S2 Cells.
Embryonic cic-Venus was expressed at endogenous levels as part of a genomic rescue
construct (Grimm et al., 2012) (Fig. 2.1B). The tagged protein and associated interactors
were purified by affinity purification, and protein complexes were analyzed by liquid
chromatography-tandem mass spectrometry (LC-MS/MS).
The identified Cic-interacting proteins were analyzed with the SAINT program
(Choi et al., 2011), which is designed to assign probability scores for bona fide proteinprotein interactions. Probability scores above 0.8 are considered highly significant. The
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A

B

Figure 2.1. Affinity purification mass spectrometry (AP-MS) method. (A) APMS work flow. (B) Schematic of Cic-SBP and Cic-Venus constructs used for
protein expression in Drosophila S2 cells and embryos, repectively.
top 20 Cic interacting proteins identified in S2 cells and embryos are shown in Table 2.1
and Table 2.2, repectively. From the S2 cells, I successfully recovered the known Cic
interactor MAPK rl (Astigarraga et al., 2007), and also identified 14-3-3 proteins, which
were previously found to interact with human Cic in HEK293T cells (Dissanayake et al.,
2011). Rolled (rl) was also identified as a top interactor in the embryo data. Interestingly,
the SCA1 disease protein, Ataxin-1 (Atx-1), was identified with a high SAINT score of
0.9487. The human homolog of Atx-1 was previously shown to interact with human CIC
(Lam et al., 2006), and my data suggest that this interaction is conserved in Drosophila.
In conclusion, I successfully recovered most of the known interactors of Cic, including
Drosophila ERK ortholog Rolled, Ataxin-1 and 14-3-3 proteins (proteins marked in red,
Fig. 2.2A).
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Protein
cic
rl
Wap
Hsp70Aa
14-3-3epsilon
Ranbp9
Hsp68
Ef1alpha100E
RpS14b
Hsc70-2
CG30382
RpS27A
sesB
14-3-3zeta
Thiolase
RagC-D
CtBP
CG8230
Roe1
CaBP1
Rab6
ms(3)72Dt

Pep. Num. in exp.
81|89
10|22
8|11
11|7
10|19
8|8
8|8
6|11
4|6
5|4
4|5
4|3
3|3
7|13
4|6
2|6
3|16
2|4
4|2
3|3
2|4
2|2

Pep. Num. in ctrl.
0|0|0|0|0
3|0|0|0|0
0|0|0|0|0
1|1|0|0|0
8|0|0|0|1
3|0|0|1|0
4|2|0|0|0
0|0|0|0|5
0|0|0|0|0
1|0|0|0|0
0|0|0|0|0
0|0|0|0|0
1|0|0|0|0
7|1|0|0|2
3|0|0|0|2
0|0|0|0|0
3|0|0|0|0
2|0|0|0|0
1|0|0|0|0
4|0|0|0|0
3|0|0|0|0
0|0|0|0|0

SAINT Probability
1
1
0.9995
0.9985
0.9965
0.994
0.9785
0.974
0.965
0.9605
0.949
0.901
0.8965
0.8745
0.8715
0.8605
0.7965
0.7755
0.77
0.737
0.7355
0.6945

Table 2.1. Statistical analysis of Cic interactome from S2 cells expressing Cic-SBP.
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Protein
cic
rl
Atx-1
cin
Klp61F
Wap
Nup358
CG1677
CG1091
Nup50
CG8108
Top2
Hsc70-5
Pgi
RanGAP
Hsp23
CG6453
Rrp1
wech
tacc
CG1218
Hcf

Pep. Num. in exp.
49|68|63
5|8|5
3|4|4
2|5|6
4|3|7
2|4|2
35|30|32
7|3|5
2|2|3
4|5|6
2|2|4
13|8|14
17|11|12
3|7|5
9|7|10
4|4|3
5|5|7
1|5|5
5|3|4
2|2|3
3|2|3
1|4|3

Pep. Num. in ctrl.
0|0|0|0|0
0|0|0|0|0
0|0|0|0|0
0|1|0|0|0
0|1|2|0|0
0|0|0|0|0
0|16|17|0|21
0|1|2|0|1
0|0|0|0|0
1|3|1|1|0
0|0|1|0|1
1|2|9|1|4
0|6|8|0|7
0|0|4|0|2
1|4|3|1|5
0|2|1|0|1
0|3|2|0|3
0|0|0|0|2
0|2|0|0|3
0|1|0|0|1
0|1|2|0|0
0|0|0|0|1

SANIT Probability
1
0.9967
0.9487
0.888
0.8613
0.8593
0.83
0.8263
0.823
0.7923
0.7257
0.718
0.7143
0.6983
0.6957
0.684
0.6777
0.6737
0.6733
0.666
0.665
0.6507

Table 2.2. Statistical analysis of Cic interactome from Drosophila embryos
expressing Cic-Venus.
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Figure 2.2. Mnb and Wap physically interact with Cic, and Wap promotes the binding
of Mnb to Cic. (A) The Cic protein interactome identified in Drosophila S2 cells
(CicS) and embryos (CicV). Thick lines, highly significant interactions. (B) Western
blots showing co-immunoprecipitation of Cic, Mnb and Wap in S2 cells. Endogenous
dpERK is stabilized by Cic expression. (C-D) Co-immunoprecipitation of Cic, Mnb,
and Wap in vivo using embryo lysates from yw (control), cic-Venus, or cic-Venus
crossed with mnb-tRFP. (E) Wap is required and sufficient to bridge Cic and Mnb. (F)
Cic mobility was changed when Cic was co-expressed with Wap and wildtype Mnb,
but not kinase-dead Mnb (MnbKR).
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Wap and Mnb interact with Cic
I hypothesized that the interactors found from both in vitro and in vivo data would
be the strongest candidates to be true Cic-interacting proteins. Cytoscape was used to
incorporate the interactome data into Fig. 2.2A for visualization. I found two hits that
were common between the cell culture and embryo data: rl and Wap. Wap is a WD40
repeat domain containing protein, which was previously reported to regulate
neuromuscular development and tissue growth (Degoutin et al., 2013; Morriss et al.,
2013). Wap is a highly conserved protein and its mammalian orthologue, DDB1 and
CUL4 associated factor 7 (DCAF7), is expressed in vertebrate muscle and the nervous
system. Wap mutant flies failed to properly form a jump muscle (Degoutin et al., 2013;
Morriss et al., 2013). Wap functions together with the kinase Minibrain (Mnb) to regulate
wing and leg tissue growth through the Hippo pathway downstream of Dachsous
(Degoutin et al., 2013). Wap interacts with both Mnb and Wts, and serves as an adaptor
to promote the Mnb-dependent phosphorylation and inhibition of Wts. The interaction
between Wap and Mnb is conserved in mammals, as the Wap ortholog DCAF7 forms a
stable complex with the dual-specificity tyrosine phosphorylation-regulated kinase 1A
(DYRK1A), which is the mammalian ortholog of Mnb (Skurat and Dietrich, 2004). The
AP-MS experiments also identified four peptides of Mnb in the Cic-SBP pulldown in S2
cells (Fig. 2.2A), suggesting that Wap, Mnb and Cic form a protein complex. Coimmunoprecipitation in S2 cells using overexpressed proteins confirmed that Cic binds to
both Wap and Mnb (Fig. 2.2B).
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To study the interactions between proteins expressed at endogenous levels in vivo,
I used tagged mnb-tagRFP-T (mnb-tRFP) and wap-Venus alleles that were generated in
Dr. Shu Kondo’s laboratory by CRISPR/Cas9-mediated homologous recombination.
Endogenous Wap was detected in the Cic-Venus complex using an anti-DCAF7 antibody
(Fig. 2.2C), and both Wap and Cic-Venus were present in Mnb-tRFP complexes isolated
from embryos expressing both Mnb-tRFP and Cic-Venus (Fig. 2.2D). Next I asked
whether Wap could serve as a bridge for the interaction between Mnb and Cic. RNAi
depletion of wap in S2 cells led to a reduction in the binding of Cic to Mnb, whereas
overexpression of Wap promoted the interaction (Fig. 2.2E). Collectively, these data
suggest that Wap, Mnb and Cic form a protein complex, with Wap likely serving as a
bridging adaptor between Cic and Mnb.

Mnb phosphorylates the amino-terminal third of Cic in S2 cells.
Given that Mnb/DYRK1A is a kinase (Degoutin et al., 2013; Tejedor et al., 1995),
I asked whether Mnb could phosphorylate Cic. Cic mobility on an SDS-PAGE was
reduced when Cic, Mnb, and Wap were co-expressed (Fig. 2.2B, E, and F). Notably, the
levels of activated ERK (dpERK) did not increase in this condition (Fig. 2.2B). In
contrast, a kinase-dead mutant of Mnb (MnbKR) (Degoutin et al., 2013) failed to reduce
Cic mobility (Fig. 2.2F), suggesting that the kinase activity of Mnb is required to reduce
Cic mobility and that this modification is likely to be phosphorylation.
To determine which region of Cic was phosphorylated by Mnb, three Cic
fragments (Cic1-3, Fig. 2.3A) were coexpressed with Wap in the presence or absence of
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Figure 2.3. Mnb and ERK target different regions of Cic for phosphorylation. (A)
Schematic diagram of the three Cic fragments (Cic1, Cic2 and Cic3) with locations of
phosphorylation sites. (B) Mnb interacts with and phosphorylates only the amino
terminal Cic fragment, Cic1. (C) Phos-tagTM gel analysis of Cic1 phosphorylation.
Bottom panel: regular SDS-PAGE. (D) Mnb phosphorylates region Cic1, whereas
activated ERK (ERKSem) phosphorylates region Cic3. (E) Summary of Cic binding and
phosphorylation data.
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Mnb in S2 cells. Only the amino-terminal fragment of Cic (Cic1, representing amino
acids 1-453) was found to interact with Mnb (Fig. 2.3B). In addition, Mnb decreased the
electrophoretic mobility of Cic1, but not Cic2 or Cic3 (Fig. 2.3B). Phos-tagTM gel
analysis confirmed phosphorylation of Cic1 by wildtype but not kinase-dead Mnb (Fig.
2.3C). Next I asked which residue(s) in Cic1 are phosphorylated by Mnb. Threonine 28 is
part of a motif in Cic1 (RSATP) that closely matches the DYRK1A phosphorylation
consensus RP(X)(S/T)P (Himpel et al., 2000). Surprisingly, mutation of this residue
(T28A) did not alter the phosphorylation pattern of Cic1 (Fig. 2.3C). To identify Cic
residues that are phosphorylated by Mnb, Cic1 and Wap were coexpressed in S2 cells
either with Mnb or MnbKR, Cic1 was purified, and its phosphorylation was analyzed by
mass spectrometry. Four Cic1 residues (S41, S49, T89, and S91) were more highly
phosphorylated by Mnb compared to MnbKR, with T89 and S91 phosphorylations found
exclusively in the wildtype Mnb sample (Figs. 2.3A and 2.4). The S41 and S49 residues
were also found to be phosphorylated in an unbiased global phosphoproteomic study in
Drosophila embryos (Zhai et al., 2008). Alanine substitutions of the four residues
resulted in a reduction of phosphorylation of Cic1, with the most pronounced effect
observed for a quadruple mutant, Cic-SSTS/A (Fig. 2.3C).
Previous studies showed that region Cic3 includes an ERK docking site and is
subject to ERK-mediated phosphorylation (Astigarraga et al., 2007; Futran et al., 2015;
Kim et al., 2010b). To compare the activities of Mnb and ERK, I co-expressed Cic1 or
Cic3 with Mnb or a constitutively active Drosophila ERK, ERKSem (Brunner et al.,
1994). Mnb could only reduce the electrophoretic mobility of Cic1 but not Cic3, whereas
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Figure 2.4. Locations of Cic phosphorylation sites identified by mass spectrometry. A
Cic1 region is shown (amino acids 1-453). The putative DYRK1A consensus is
underlined, and the corresponding residue (T28) is highlighted in blue. T28
phosphorylation was not detected by mass spectrometry. S41 and S49 (green) were
more highly phosphorylated in wildtype Mnb samples compared to MnbKR. T89 and
S91 phosphorylations (red) were found exclusively in the wildtype Mnb samples.
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ERKSem only reduced the electrophoretic mobility of Cic3 but not Cic1 (Fig. 2.3D).
Collectively, these results suggest that Mnb and ERK target different regions of Cic for
phosphorylation: Wap facilitates Mnb-dependent phosphorylation of the amino-terminal
third of Cic, whereas ERK targets the carboxy-terminal region (Fig. 2.3E).

Mnb and Wap reduce Cic repressor activity
Previous studies have shown that phosphorylation of Cic by ERK can result in
downregulation of Cic by lowering its repressor activity, protein level, or nuclear
localization (Ajuria et al., 2011; Astigarraga et al., 2007; Lim et al., 2013). I hypothesized
that Mnb may exert similar effects. First, I used the CoinFLP-GAL4 system (Bosch et al.,
2015) to generate RNAi-depletion clones in the eye imaginal discs (Fig. 2.5A). As
expected, I observed reduced levels of Cic protein in UAS-cic-RNAi clones (Fig. 2.5B).
However, no obvious increase in Cic protein level or change in subcellular localization
was found in CoinFLP-generated UAS-mnb-RNAi clones (Fig. 2.5C). Therefore, Mnb is
unlikely to control Cic at the level of protein turnover or nuclear access.
It has been shown that the relief of Cic repressor function by ERK does not
necessarily require reduction in Cic protein levels (Lim et al., 2013). To assess whether
Mnb could similarly affect Cic repressor activity, I used a reporter, CUASC-lacZ, which
contains five GAL4 binding sites flanked on either side by two Cic binding motifs (Fig.
2.6A) (Ajuria et al., 2011). This reporter is only responsive to GAL4 in areas where Cic
activity is inhibited, e.g. by RTK signaling (Fig. 2.6B). Uniform induction of GAL4
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Figure 2.5. RNAi depletion of Mnb does not increase Cic levels in imaginal eye discs.
(A-C’’) Mosaic eye discs of the indicated genotypes generated using CoinFLP-GAL4
and stained with anti-Cic antibody (red). GAL4-positive cells are marked with UASGFP (green). (A-A’’) Control clones do not affect Cic protein levels. (B-B’’)
Knockdown of cic reduces Cic protein levels. (C-C’’) Knockdown of mnb does not
increase Cic protein level or change Cic subcellular localization. Scale bar, 50 μm.
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Figure 2.6. Mnb reduces Cic repressor activity. (A) Diagram of the CUASC-lacZ
reporter. (B) Summary diagram of expression patterns. (C-G) LacZ expression pattern
resulting from C5-GAL4-directed activation of CUASC-lacZ in wing discs from
control (C), UAS-cicRNAi1 (D), UAS-cic (E), UAS-mnb (F), and UAS-mnbRNAi (G)
larvae. Scale bar, (C-G), 50 μm.
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expression in the wing pouch under the control of the C5-GAL4 driver (Yeh et al., 1995)
resulted in a localized activation of LacZ expression in prospective veins (Fig. 2.6C).
This pattern results from Epidermal Growth Factor Receptor (EGFR)/ERK-mediated
inactivation of Cic in these regions (Fig. 2.6B) (Ajuria et al., 2011). RNAi depletion of
cic or overexpression of ERKSem throughout the wing pouch led to a much broader
expression of LacZ (Figs. 2.6D and 2.7B), confirming that the normal restriction of the
expression pattern of CUASC-lacZ to prospective veins is Cic dependent. In contrast,
overexpression of Cic resulted in the loss of LacZ expression in the vein L5 region (Fig.
2.6E, open arrowhead). Overexpression of Mnb or Wap induced a broader LacZ
expression in the wing pouch (Figs. 2.6F and 2.7C). Conversely, RNAi depletion of mnb
or wap under the control of C5-GAL4 resulted in reduced LacZ expression, particularly in
vein L5 (Figs. 2.6G and 2.7D). These data suggest that Mnb and Wap limit Cic repressor
function in the wing disc. This contribution likely complements the regulation by ERK,
which appears to be insufficient on its own, at least for vein L5 (Fig. 2.6B).
Mnb and Wap have been shown to phosphorylate and inhibit Warts, which results
in elevated Yki activity (Degoutin et al., 2013). To test whether CUASC-lacZ expression
was affected by Hippo signaling, I depleted the levels of the Yki-interacting transcription
factor Scalloped (Sd), which is required for the activation of Yki targets (Zhang et al.,
2008). I observed that knockdown of sd using RNAi had no obvious effect on the
expression of CUASC-lacZ (Fig. 2.7E), suggesting that Hippo signaling is not involved in
the regulation of Cic repressor activity in this context. To further assess whether Mnb and
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Figure 2.7. Modulation of Cic repressor activity by Mnb and Wap does not require Sd
and does not affect activity of ERK. (A-E) LacZ expression pattern resulting from C5GAL4-directed activation of CUASC-lacZ in wing imaginal discs from control (A),
UAS-ERKSem (B), UAS-wap (C), UAS-wapRNAi (D), and UAS-sdRNAi (E) larvae.
Expression of ERKSem and Wap led to a broader activation of the reporter (B, C),
whereas knockdown of wap resulted in lower LacZ expession, particularly in
presumptive vein L5 (D). Knockdown of sd did not alter the normal pattern of
expression in presumptive veins. (F-H) dpERK expression pattern in wing discs from
control (F), C5-GAL4>UAS-mnbRNAi (G), and C5-GAL4>UAS-wapRNAi (H) larvae.
Scale bar, 50 μm.
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Wap engage RTK/ERK signaling to control Cic, I analyzed dpERK levels in wing
pouches expressing mnb-RNAi or wap-RNAi. I found that RNAi depletion of wap or
mnb did not alter the dpERK pattern in wing discs (Figs. 2.7F-H). This result is in
agreement with the observation that overexpression of Mnb did not increase dpERK
levels in S2 cells (Fig. 2.2B). I conclude that Mnb and Wap downregulate Cic repressor
activity independently from the RTK/ERK and the Hippo pathways.
To directly address how Mnb and Wap affect Cic function as a transcriptional
repressor, I studied the activity of a reporter, CUASC-Luc, which is controlled by GAL4
and Cic, in S2 cells (Fig. 2.8A). Transfection of GAL4 activated this reporter ~10-fold,
and this activation was repressed by co-expression of Cic in a dose-dependent manner
(Fig. 2.8B). Depletion of endogenous mnb, wap, or rl (ERK) by RNAi resulted in a
reduction of reporter activity (Fig. 2.8C), suggesting that Mnb, Wap and ERK are
required to limit the activity of Cic. I next tested whether Mnb and Wap could reduce the
capacity of Cic to repress CUASC-Luc expression, and found that co-transfection of Cic
with Mnb and Wap partially relieved Cic-mediated repression of this reporter (Fig. 2.8D).
Whereas the Cic-SSTS/A mutant repressed the reporter gene expression to a similar level
as wildtype Cic, co-expression of this mutant with Mnb and Wap did not affect its ability
to repress CUASC-Luc (Fig. 2.8D). Collectively, these results indicate that Mnb and Wap
reduce the activity of Cic as a transcriptional repressor, likely via Mnb-mediated
phosphorylation of residues located in the amino terminus of the Cic protein.
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Figure 2.8. Mnb and Wap reduce Cic repressor activity in Luciferase assay. (A)
Schematic diagram of the CUASC-Luc reporter construct. (B) Dose-dependent
repression of CUASC-Luc expression by Cic. S2 cells were co-transfected with the
reporter CUASC-Luc, pMT-GAL4 and decreasing amounts of Cic expressing plasmid
(500 ng, 250 ng, 125 ng). The values shown are fold changes over the negative
control set at 1. (C) mnb, wap, and rl (ERK) are required to limit the activity of Cic.
(D) Mnb and Wap reduce transcriptional repressor activity of wildtype Cic, but not of
the phosphorylation site mutant, Cic-SSTS/A. n.s., not significant, * p<0.05, **
p<0.01, *** p<0.001, Statistical significance was analyzed using unpaired Student’s t
test. Error bars represent standard deviation.
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Mnb opposes Cic function in controlling wing and eye growth.
I next investigated whether the inhibitory effects of Mnb/Wap on Cic were
involved in the control of organ growth. Overexpression of Mnb using the wing pouch
MS1096-GAL4 driver (Capdevila and Guerrero, 1994) promoted wing growth (Figs. 2.9B
and G). Conversely, overexpression of Cic or the Cic-SSTS/A mutant resulted in a
reduction of wing size (Figs.2.9C, E and G). Whereas coexpression of Mnb with Cic
suppressed the smaller wing size associated with Cic overexpression (Figs. 2.9C, D, and
G), coexpression of Mnb with Cic-SSTS/A did not modify this phenotype (Figs. 4E, F,
and G). These data suggest that Mnb regulates Cic function at least in part through the
phosphorylation of the SSTS residues. I also asked whether mnb and cic would display
opposing effects on growth in a reduction-of-function context. RNAi depletion of cic
using the MS1096-GAL4 driver caused a severe defect in wing development. I thus used a
weaker driver, C96-GAL4, which is expressed primarily around the wing margin (Helms
et al., 1999), to study the effects of reduced levels of mnb and cic. Knockdown of cic
caused wing overgrowth (Figs. 2.9I, L), and RNAi depletion of mnb resulted in an
opposite effect (Figs. 2.9J, L). Importantly, RNAi depletion of cic partially rescued the
small wing phenotype induced by expression of mnb-RNAi (Figs. 2.9K, J). Mutually
antagonistic effects of Mnb and Cic on growth were also observed in the eye (Fig. 2.10).
Collectively, I conclude that Mnb and Wap promote wing and eye growth by
antagonizing the growth-restricting function of Cic.
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Figure 2.9. Mnb opposes Cic function in controlling wing growth. (A-F) Wings from
adult female flies expressing UAS-GFP as a control (A), UAS-mnb (B), UAS-cic (C),
UAS-mnb together with UAS-cic (D), UAS-cic-SSTS/A (E), and UAS-mnb together with
UAS-cic-SSTS/A (F) using the MS1096-GAL4 driver. (G) Quantification of the wing
areas for the genotypes shown in (A-F) (n=20 for each genotype). (H-K) Wings from
adult female flies expressing UAS-GFP as a control (H), UAS-cicRNAi1 (I), UAS-mnbRNAi
(J), and UAS-cicRNAi1 together with UAS-mnbRNAi (K) using the C96-GAL4 driver. (L)
Quantification of the wing areas for the genotypes shown in (H-K) (n=20 for each
genotype). * p<0.05, ** p<0.01, *** p<0.001. Statistical significance was analyzed
using Student’s t test. Error bars represent standard deviation. Scale bar, 200 μm.
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Figure 2.10. Mnb opposes Cic function in controlling eye growth. (A-D) Adult female
flies expressing UAS-GFP (A), UAS-cicRNAi1 (B), UAS-mnb-RNAi (C), and UAS-mnbRNAi together with UAS-cicRNAi1 (D) under the control of the da-GAL4 driver.
Knockdown of mnb results in a smaller eye (C), which is reversed by a concomitant
knockdown of cic (D). Scale bar, 100 μm.
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Reduction of cic level restores adult brain size in mnb mutants.
Mnb was originally identified in a genetic screen for mutants with altered brain
structure (Tejedor et al., 1995). Mutant mnb adult animals have smaller brains, with the
optic lobes (OLs) most significantly affected (Tejedor et al., 1995). In Drosophila
development, the size of the central brain (CB) is determined by the proliferative ability
of the neuroblasts (NBs) that are of embryonic origin, whereas the OLs are generated by
the neuroepithelium (NE) which gives rise to the OL NBs during the larval stages (SousaNunes et al., 2010). In order to identify the tissue origins of the reduction in adult brain
size, the larval and pupal brains from the wildtype and mnbd419 animals were analyzed
(mnbd419 is a null allele, (Hong et al., 2012)). The volumes of the larval and pupal brains
in the mnbd419 mutants were significantly smaller than controls (Fig. 2.11), suggesting
that the effects of loss of mnb can be traced to these developmental stages. I asked
whether the smaller OLs in mnb mutants could result from altered proliferation in the NE
and/or NB regions during the larval stages. The widths of both the NB and NE regions in
the larval brains from mnbd419 animals were significantly reduced, compared to controls
(Figs. 2.12A-D, G, H). Conversely, overexpression of Mnb in MARCM clones resulted
in an increase of the width of NE specifically in the clone area (Figs. 2.12E and F). These
results suggest that Mnb is required for the proper growth of both the NE and NB regions
in the OL. Additionally, Mnb may be involved in controlling the timing of NE to NB
differentiation (Reddy et al., 2010).
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Figure 2.11. Loss of mnb leads to smaller brain size in larvae and pupae. (A, B) Third
instar larval brains from control (w1118) (A) and mnbd419 (B) animals. (C)
Quantification of the larval brain volumes in (A, B) (n=2, 4). (D, E) Pupal brains from
control (w1118) (D) and mnbd419 (E) animals. (F) Quantification of the pupal brain
volumes in (D, E) (n=4, 4). * p<0.05. Statistical significance was analyzed using
Student’s t test. Scale bars, 100 μm. These data were obtained in collaboration with
Francesca Froldi (Cheng Lab).
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Figure 2.12. Loss of mnb leads to thinner Neuroblast (NB) and Neuroepithelium (NE)
regions in larvae. (A, B) NB regions (Mira-positive cells) in larval CNS from control
(w1118) (A) and mnbd419 animals (B). (C, D) NE regions (E-cad positive cells) in larval
CNS from control (w1118) (C) and mnbd419 animals (D). (E, F) NE region is expanded
cell-autonomously in UAS-mnb overexpression clones (marked in green in E). Dotted
red line: clone areas; solid red line: boundary between NB and NE. (G) Quantification
of results in (A, B) (n=9, 4). (H) Quantification of results in (C, D) (n=5, 4). Scale
bars: 50 μm *p<0.05, **p<0.01, ***p<0.001. Error bars represent standard deviation.
Statistical significance was analyzed using Student’s t test. These data were obtained
in collaboration with Francesca Froldi (Cheng Lab).
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Next I asked whether interactions between cic, mnb and wap were involved in the
control of adult brain size. RNAi knockdown of mnb or wap with a ubiquitous da-GAL4
driver (Wodarz et al., 1995) resulted in a smaller adult brain, especially in the optic lobes
(Figs. 2.13A, C and G). This result suggests that both Mnb and Wap are required for
normal brain growth. Knockdown of cic resulted in an increased adult brain size (Figs.
2.13B and G). Strikingly, depletion of cic strongly suppressed the small brain phenotype
caused by the knockdown of mnb (Figs. 2.13C, E and G), suggesting that Mnb promotes
brain growth via downregulation of Cic. Similarly, RNAi depletion of cic rescued the
smaller brain phenotype of wap-RNAi (Figs. 2.13D, F and G). Overall, these results
implicate Cic, Mnb and Wap in a common pathway controlling organ growth, and
suggest that at least some of the growth-promoting functions of Mnb and Wap are
mediated via their inhibition of Cic activity.
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Figure 2.13. Reduction in cic level restores adult brain size in mnb mutants. (A-G)
Brains from adult female flies with the indicated genotypes. da-GAL4 driver was used
to drive the expression of UAS-GFP (A), UAS-cicRNAi1 (B), UAS-mnbRNAi (C), UASwapRNAi (D), UAS-cicRNAi1 together with UAS-mnbRNAi (E), or UAS-cicRNAi2 together
with UAS-wapRNAi (F). Ph, phalloidin stain. (G) Quantification of brain volumes for
the genotypes shown in (A-F) (n=8 for each genotype). Scale bars: 100 μm. *p<0.05,
*p<0.05, **p<0.01, ***p<0.001. Error bars represent standard deviation. Statistical
significance was analyzed using Student’s t test.
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Figure 2.14. Deletion of the C2 motif does not affect the binding between Cic and
Mnb. Protein lysates from S2 cells transfected with the indicated plasmids were
incubated with anti-V5 beads, and immunocomplexes were analyzed on western blots
probed with anti-V5, anti-HA, and anti-tubulin antibodies.
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Mnb and ERK have additive effects on Cic activity
This study so far has shown that Mnb is required for inhibiting Cic activity in
various tissue contexts, which is also how ERK transmits signals from RTKs to control
growth and patterning. Next I asked whether the effects of ERK and Mnb on Cic are
additive, by first individually and then simultaneously reducing their ability to inhibit
Cic. ERK-mediated downregulation of Cic depends on the conserved C2 motif located in
region Cic3, which serves as the ERK docking site (Astigarraga et al., 2007). Deletion of
the C2 motif abrogated Cic-ERK interaction (Astigarraga et al., 2007), and a single
amino acid substitution, F1054A, in the C2 motif (QQFILAPTPAQLG) reduced the
binding of Cic to ERK (Futran et al., 2015). Importantly, deletion of the C2 domain did
not affect the binding of Cic to Mnb (Fig. 2.14).
Using CRSPR/Cas9-mediated mutagenesis, our collaborators from Jiménez
laboratory generated an allele (cic3) lacking residue F1054, which is predicted to
specifically disrupt the interaction of Cic with ERK. Most of the cic3 mutant animals
showed normal wing vein pattern (Figs. 2.15A and B), however a partial loss of vein L5
was observed in approximately 30% of adult flies, indicating that this is a gain-offunction mutation. RNAi depletion of mnb using C5-GAL4 resulted in a partial loss of
veins L4 and L5 (Fig. 2.15C, arrowheads), which is in agreement with our observation
that CUASC-lacZ expression was lost in the L5 region in this background (see Fig. 2.6G).
I reasoned that if Mnb and ERK had additive effects on Cic activity, reduction of mnb
level in the cic3 background would cause a more severe vein loss phenotype, compared to
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Figure 2.15. Mnb and ERK function additively to inhibit Cic. (A-D) Wings from adult
female flies of the following genotypes: C5-GAL4 (A), C5-GAL4 cic3/+ (B), C5GAL4/UAS-mnbRNAi (C), C5-GAL4 cic3/UAS-mnbRNAi (D). Scale bar: 200 μm. These
data were obtained in collaboration with Marta Forés (Jiménez Lab).
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depletion of mnb alone. Indeed, I observed not only a more severe loss of veins L4 and
L5, but also partial loss of veins L2 and L3 in the C5>mnbRi; cic3 animals (Fig. 2.15D). I
conclude that Mnb and ERK function additively to regulate wing tissue patterning via
inhibition of Cic activity.

2.3 Discussion
Our knowledge of upstream signals controlling Cic activity has been largely
limited to its regulation by the RTK/ERK pathway (Jimenez et al., 2012). In this study, I
have identified a previously unknown mechanism for the regulation of Cic by the kinase
Mnb and its adaptor Wap. Wap facilitates Mnb-dependent phosphorylation of Cic in the
amino-terminal region, which is necessary for downregulation of Cic activity. I found
that the primary mechanism of Cic downregulation by Mnb is through the relief of Cicdependent transcriptional repression. Mnb-dependent downregulation of Cic is necessary
for the proper growth of multiple organs and correct patterning of tissues.
In this study, I have used AP-MS to identify Mnb and Wap as novel Cicinteracting proteins. Co-immunoprecipitation experiments from 0-16 h Drosophila
embryos have shown that Mnb, Wap and Cic interact with each other in vivo. I have
shown that Mnb interacts with and phosphorylates the amino-terminal third of the Cic
protein. However, it is still not known how Mnb interacts with Cic. Future studies are
required to elucidate the structural basis for the interaction between Mnb and Cic. It may
be informative to screen for the inhibitors specifically disrupting the Mnb-Cic interaction.
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The Mnb-Cic interaction and phosphorylation is different from the ERK-mediated
phosphorylation of Cic, as previous reports showed that ERK interacts with Cic through
C2 motif located in the carboxyl-terninal third of Cic (Astigarraga et al., 2007; Futran et
al., 2015). This distinct Mnb-mediated phosphorylation of the amino-ternimal third of Cic
results in at least 4 phosphorylation sites (S41, S49, T89, and S91), as revealed by a
kinase assay. It would be informative to perform an in vitro kinase assay to survey the
ERK-dependent phosphorylation sites on Cic. This assay will allow us to have a better
understaning of the functional outcomes of Cic phosphorylations.
Unlike ERK-mediated phosphorylation, Mnb does not affect Cic protein level or
cellular localization. Instead, I found that Mnb only inhibits Cic transcriptional repressor
activity. However, the molecular details of this inhibition are still not clear. One possible
explanation is that Mnb-mediated phosphorylation of Cic interferes with the binding of
the Cic protein to its target DNA sequences, despite the fact that no phosphorylation site
in the HMG box region has yet been identified. Therefore, it is worth performing a
thorough kinase assay to identify all possible Mnb-dependent phosphorylation sites in
full-length Cic. Previous studies showed that the repression of RTK target genes requires
co-repressors such as Groucho (Gro) (Astigarraga et al., 2007; Cinnamon et al., 2008).
Another possible reason for a reduction in Cic repressor function could be that Mnbmediated phosphorylation of Cic disrupts its binding to the co-repressors, which in turn
reduces its transcriptional repressor activity.
According to the current model (Fig 1.3), the RTK activation results in the
phosphorylation of ERK, which in turn phosphorylates and downregulations Cic. This
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RTK/ERK mediated regulation of Cic allows the derepression of RTK target genes,
which are essential for development, patterning and growth. Therefore, Cic was regarded
as a general sensor of RTK signaling (Jimenez et al., 2012). At least two RTKs function
as upstream inputs into Cic signaling to regulate multiple cellular responses. Torso
signaling functions through Cic to regulate embryo tissue patterning in Drosophila
(Cinnamon et al., 2004; de las Heras and Casanova, 2006; Jimenez et al., 2000). EGFR
signals are transduced through Cic to control patterning, differentiation, and proliferation
(Ajuria et al., 2011; Atkey et al., 2006; Blair, 2007; Goff et al., 2001; Jiang et al., 2011;
Jin et al., 2015; Roch et al., 2002). However, little is known about the upstream
regulatory mechanisms of Mnb and Wap.
Mnb is expressed and required in neuroblast proliferation centers during
neurogenesis, but what upstream signals activate Mnb is still unknown (Tejedor et al.,
1995). One study revealed that Mnb formed a transitional intermediate during translation,
which phosphorylates tyrosine326 in the activation loop of the kinase domain. This
autophosphoryaltion is an intramolecular event. Once Mnb is released from the ribosome,
tyrosine kinase activity is lost, and the Mnb kinase only functions as a serine/threonine
kinase (Lochhead et al., 2005). Its mammalian homologue, DYRK1A, also relies on
autophosphorylation of the conserved tyrosine321 in the activation loop of the kinase
domain. In addition, autophosphorylation is not restricted to tyrosine321. A study showed
that DYRK1A also autophosphorylates on serine520 in the PEST domain, which is
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important for its interaction with 14-3-3 proteins (Alvarez et al., 2007). Given that the
DYRK family kinases autoactivate themselves soon after translation (Becker and Sippl,
2011), it is likely that the effects of Mnb and Wap on Cic are constitutive.
Inhibition of Cic activity by Mnb/Wap has two developmentally important
consequences (Fig. 2.16). First, this regulation is important for the proper growth of
several organs, such as the wings, eyes, and the brain. Second, downregulation of Cic
activity by Mnb/Wap is required for proper tissue patterning. Given the broad expression
patterns of Cic, Mnb, and Wap, the inhibitory mechanism I describe appears to operate in
most, if not all, cells. In relation to ERK, the contribution from Mnb and Wap to Cic
downregulation depends on the tissue context and includes three possible scenarios: in
some cells (e.g. developing vein L5 in the wing), both pathways are required for
complete inhibition of Cic and operate additively. In other cells, ERK is the primary
inhibitory signal, whereas the contribution of Mnb/Wap is less prominent (e.g. veins L2
and L3). Finally, in yet other cells in which ERK is not active, the function of Mnb and
Wap to limit Cic activity would be dominant.
In addition to the RTK/ERK pathway, Cic was also shown to be regulated by
Hippo signaling (Herranz et al., 2012), and we have previously implicated Mnb and Wap
as Hippo pathway regulators downstream of Dachsous (Degoutin et al., 2013). In this
study, I found that knockdown of sd, a required component of Hippo signaling, did not
affect the pattern of expression of CUASC-LacZ, and that knockdown of mnb or wap did
not alter the pattern of ERK activation (Fig. 2.7), suggesting that Mnb and Wap control
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Figure 2.16. Cic integrates upstream signals to control organ growth and tissue
patterning.

Cic activity independently from ERK and Hippo signaling. Altogether, current evidence
suggests that Cic functions as an integrator of upstream developmental signals that
converge on Cic to limit its activity, which is necessary for the proper execution of
developmental programs responsible for tissue patterning and organ growth (Fig. 2.16).
Cic controls these developmental programs by direct binding to the enhancers of the
genes encoding regulators of tissue patterning and cell proliferation in Drosophila and
mammals (Ajuria et al., 2011; Fores et al., 2015; Jin et al., 2015; Kawamura-Saito et al.,
2006).
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Interactions between Mnb/Wap and Cic in the brain have interesting parallels in
human biology. The majority (>70%) of oligodendrogliomas, which are aggressive brain
tumors, have been recently shown to harbor loss-of-function mutations in CIC,
suggesting that it functions as a tumor suppressor (Sahm et al., 2012; Wesseling et al.,
2015). Higher expression of DYRK1A was also found in a subset of oligodendroglioma
patient samples (Pozo et al., 2013), raising a possibility that DYRK1A may suppress Cic
activity in human cells, much like Mnb does in Drosophila. A connection between
DYRK1A and Cic in controlling brain development may extend even deeper, since both
proteins have been implicated in neurodegenerative diseases (Guimera et al., 1996; Lam
et al., 2006; Moller et al., 2008; Tejedor and Hammerle, 2011).

2.4 Materials and Methods
Drosophila melanogaster Stocks
All Drosophila stocks were maintained on standard yeast-cornmeal-agar medium
at 25°C or 18°C as indicated. MS1096-GAL4, da-GAL4, C96-GAL4, en-GAL4 and hhGAL4 UAS-GFP, ey-FLP UAS-dcr2 (#58757), CoinFLP UAS-GFP (#58751) were from
the Bloomington Drosophila Stock Center. UAS-wap RNAi (KK 107076), UAS-mnb
RNAi (GD 28628), UAS-cic RNAi1 (KK 103012), UAS-cic RNAi2 (GD 40867), UAS-sd
RNAi (KK 101497) were from the Vienna Drosophila Resource Center (VDRC). UAScic, UAS-mnb, UAS-wap were made using standard cloning methods, and transgenic lines
were generated by Genetic Services, Inc (Cambridge, MA). Cic-Venus is a genomic Cic
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rescue construct from (Grimm et al., 2012). Other stocks were C5-GAL4 and CUASClacZ (Ajuria et al., 2011), mnbd419 (Hong et al., 2012), mnb-tagRFP-T and wap-Venus
(Poon et al., 2016). The targeting vectors comprised the tagRFP-T (Shaner et al., 2008) or
Venus gene, the 3xP3-RFP gene for transformant selection and 1-kb homology arms. The
vectors were designed such that the fluorescent protein gene is inserted immediately in
front of the stop codon of the target gene and expressed as a fusion protein. The cic3
allele was obtained by CRISPR/Cas9-mediated mutagenesis. A guide RNA (gRNA)
sequence (5’-GTGGGTGCCAAAATAAACTGC-3’) targeting the C2 coding sequence
was subcloned in vector pCFD3 (Port et al., 2014) and inserted at the attP40 genomic site
via PhiC31-based integration. Transgenic gRNA males were crossed to nanos-cas9
females, and the resulting founder males were then crossed to TM3-bearing females for
recovery of mutations. Induced alleles were identified by sequencing PCR products
amplified from candidate flies.
Immunohistochemistry and Immunoblotting
Primary antibodies were: mouse anti-β-galactosidase (LacZ) 1:100 (Promega),
mouse anti-dpERK 1:100 (Sigma), rabbit anti-GFP 1:1,000 (Abcam), mouse anti-V5
1:1,000 (Sigma), rabbit anti-Flag 1:1,000 (Sigma), rabbit anti-HA 1:1,000 (Sigma),
guinea pig anti-Cic 1:100 (gift from Iswar Hariharan, University of California, Berkeley),
rabbit anti-DCAF7 1:100 (Novus Biologicals), rabbit anti-tRFP 1:1000 (Evrogen), mouse
anti-Mira 1:100 (gift from Alex Gould), mouse anti-Ecad 1:50 (Developmental Studies
Hybridoma Bank), mouse anti-Engrailed 1:5 (Developmental Studies Hybridoma Bank).
Secondary antibodies used were: Alexa Donkey anti Rabbit-647 (Life Technologies),
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Alexa Donkey anti-Mouse 488 (Abcam), Alexa Donkey anti-Rabbit 555 (Life
Technologies), IRDye 800CW Donkey anti-Rabbit IgG (LI-COR), IRDye 680CW
Donkey anti-Guinea pig IgG (LI-COR), IRDye 680CW Donkey anti-Mouse IgG (LICOR). Dissected imaginal discs were stained as in (Degoutin et al., 2013). Stained tissues
were mounted with Prolong Gold anti-fade mounting reagent with DAPI (Life
Technologies), and images were acquired with Zeiss LSM 510 or Zeiss LSM 880
confocal microscopes. Tissues from the Mnb-tRFP, Wap-Venus, Cic-Venus stocks were
mounted in 90 percent glycerol and images were acquired with the Nikon C2 confocal
microscope and processed in Fiji.
Quantification of Wing and Brain Size
Wing area from 20 flies was quantified using Adobe Photoshop. For
quantification of brain size, flies were raised at 18°C. Brains from 8 ten-days old female
flies were dissected in cold 1x PBS, fixed with 4% formaldehyde/PBS and stained with
Alexa Fluor 594 Phalloidin (Life Technologies) overnight. Stained brains were mounted
with Prolong Gold anti-fade mounting reagent with DAPI (Life Technologies). Brain
volume measurements were done from 3D reconstructions of 2.5 µm-spaced confocal Zstacks acquired with a Zeiss LSM 880 or Leica SP5 confocal microscopes, using a 3D
Viewer plugin in Fiji or Volocity software. Significance was calculated with a
Student’s t-test. In all figures, the following indications are used: * p<0.05, ** p<0.01,
*** p<0.001.
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Expression Plasmids and Cell Culture
For establishing a stable S2 cell line, full-length Cic open reading frame was
tagged with streptavidin binding peptide (SBP) at the C terminus and cloned into pMK33
vector (Kyriakakis et al., 2008). Full-length open reading frame and fragments of Cic
were cloned into pMT/V5-His A vector (Invitrogen). Full-length Wap was tagged with
the Flag tag and cloned into the pMT vector. pMT-Mnb-HA and pMT-MnbKR-HA
plasmids were from (Degoutin et al., 2013). The pGL2-CUASC-Luc (“CUASC-Luc”)
reporter was generated by PCR amplification of the promoter regions of pC4PLZCUASC vector (Ajuria et al., 2011) with primers CUASC-XhoI-UP1 (5’ATCGCTCGAGGAATTCCCAGTTTATG-3’) and CUASC-XhoI- DN1 (5’GCTACTCGAGTTATCACCCACGGCTCTGCTC-3’), which was subcloned into pGL2
basic (Promega). Full-length GAL4 was cloned into pMT/V5-His A vector (Invitrogen)
to generate pMT-GAL4. pIE4-lacZ was described previously (Frolov et al., 2001).
Drosophila S2 cells were maintained in standard Schneider’s S2 medium with fetal
bovine serum (Gibco) at 25°C, and transfections were performed using Effectene
transfection reagent (Qiagen). In some instances, cells were treated with 30 µg dsRNA
specific for wap, mnb or rl (ERK) for 96 h. After 96 h, cells were transfected with
indicated plasmids. CuSO4 was added to culture media at a final concentration of 0.35
mM for inducing expression. Cells were lysed using Default Lysis Buffer (DLB) (50 mM
Tris pH 7.5, 125 mM NaCl, 5% glycerol, 0.2% IGEPAL, 1.5 mM MgCl2, 1 mM DTT, 25
mM NaF, 1mM Na3VO4, 1mM EDTA and 2x Complete protease inhibitor, Roche). Clear
cell lysates were incubated with anti-V5 beads (Sigma), streptavidin beads (Pierce), GFP66

Trap or RFP-Trap resin (ChromoTek) for 2 hrs at 4°C. Beads were washed three times
with lysis buffer, and protein complexes were eluted with SDS buffer. To visualize
differences in Cic1 mobility, 6% Tris-Glycine gels were used with 50 µM Phos-tagTM
(Wako Laboratory Chemicals) and 100 µM MnCl2.
Luciferase Reporter Assays
S2 Cells were co-transfected with the luciferase reporter vector pGL2-CUASCLuc and with the effector plasmids. pIE4-LacZ was used to normalize transfection
efficiencies. Each transfection point was assayed in triplicate, and each experiment was
repeated three times. Luciferase and β-galactosidase activities were measured in S2 cell
lysates by Luc-Screen® Extended-Glow Luciferase Reporter Gene Assay System
(Thermo Fisher) and Galacto-Star™ One-Step beta-Galactosidase Reporter Gene Assay
System (Thermo Fisher), respectively. Luminescence signals were acquired on
POLARstar Omega multifunction microplate reader (BMG Labtech).
Mass Spectrometry
Cic-interacting proteins were purified from Drosophila S2 cells (Cic-SBP)
essentially as described in (Kyriakakis et al., 2008), using a modified single-step
procedure for SBP-tagged Cic. For expression in S2 cells, pMK33-Cic-SBP construct
was transfected using Effectene transfection reagent (Qiagen), and stable cell lines were
selected in the presence of 300 µg/mL hygromycin (Sigma). Cic-SBP purifications were
performed in 2 biological replicates. To analyze Cic complexes in vivo, 0-16 hr CicVenus embryos were collected and the proteins were extracted and purified on GFP-Trap
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resin (ChromoTek) as described in (Neumuller et al., 2012). The Cic-Venus construct
uses genomic regulatory sequences of the cic gene and therefore expresses the Cic-Venus
protein at endogenous levels (Grimm et al., 2012). Functionality of this construct was
previously confirmed in a rescue assay (Grimm et al., 2012). Cic-Venus purifications
were performed in 3 biological replicates. Protein complexes were analyzed by nanoLCMS/MS as described in (Kyriakakis et al., 2008) at the Taplin Mass Spectrometry Facility
at Harvard Medical School. Identified Cic-interacting proteins were analyzed by the
SAINT program (Choi et al., 2011). A complete mass spectrometry dataset is shown in
Table S1. Interactions with SAINT scores >0.8 were considered significant.
To identify Cic residues that are phosphorylated by Mnb, Cic1-V5 and Wap-Flag
were coexpressed in S2 cells either with Mnb-HA or MnbKR-HA, Cic1-V5 was purified
on anti-V5 agarose resin, and its phosphorylation was analyzed by nanoLC-MS/MS.
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CHAPTER 3
CONCLUSION

The work presented in this dissertation aimed to identify novel regulators that
control developmental processes through a critical node, Cic, in a signaling network. This
work started with addressing an open question: What are the Cic-interacting proteins?
Current proteomic studies of signaling interactomes are limited to cultured cells
(Friedman et al., 2011; Kwon et al., 2013). My research used affinity purification-mass
spectrometry (AP-MS) to study the Cic interactome in both S2 cells and the developing
Drosophila embryos. This unbiased approach provided a comprehensive understanding
of Cic signaling at a systems level in vivo.
I identified the Minibrain kinase (Mnb) and the adaptor protein, Wings apart
(Wap), as novel Cic-interacting proteins. Furthermore, I employed various molecular
biology tools, including co-immunoprecipitation (CoIP), RNA interference (RNAi),
mutagenesis, in vitro kinase assay, mass spectrometry (MS), to characterize the
interactions between Cic, Wap, and Mnb, and phosphorylation of Cic by Mnb. I found
that Mnb interacts with Cic via amino-terminal third of Cic protein, which is distinct
from the interaction between ERK and Cic. In addition, I showed that Mnb and ERK
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target different regions of Cic protein for phosphorylation. I discovered 4 Mnb-dependent
phosphorylation residues (S41, S49, T89, and S91) in the amino-terminal region of Cic.
The functional importance of these residues was confirmed in luciferase and in vivo
assays.
This study also investigated the consequences of Mnb-mediated phosphorylation
of Cic. By using reporter assays, I showed that Mnb inhibits Cic transcriptional repressor
activity in Drosophila wing imaginal discs and in S2 cells. Alanine substitution of the 4
putative Mnb phosphorylation residues (S41, S49, T89, and S91) resulted in a form of
Cic that was resistant to the inhibition by Mnb, suggesting that Mnb and Wap reduce Cic
repressor activity via Mnb-mediated phosphorylation of these residues. One question still
unanswered is how Mnb-mediated phosphorylation of Cic reduces Cic activity.
Answering this question would elucidate how Mnb downregulates Cic.
In this study, I investigated the effects of Mnb on Cic in multiple developmental
contexts. Most notably, the downregulation of Cic by Mnb is required for the proper
growth of several organs, such as the wings, eyes, and the brain. In addition, I discovered
that the downregulation of Cic by Mnb is required for proper tissue patterning. Finally, I
showed that Mnb functions additively with ERK to regulate Cic. Altogether, I uncovered
a previously unknown mechanism of Cic regulation which acts in parallel to other
signaling pathways.
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APPENDIX
SINGLE-STEP AFFINITY PURIFICATION OF ERK SIGNALING COMPLEXES
USING THE STREPTAVIN-BINDING PEPTIDE (SBP) TAG

This section was adapted from Yang, L. and Veraksa, A. (2016) Single-step affinity
purification of ERK signaling complexes using the streptavidin-binding peptide (SBP)
tag. Methods in Molecular Biology (in press)

Summary
Elucidation of biological functions of signaling proteins is facilitated by studying
their protein-protein interaction networks. Affinity purification combined with mass
spectrometry (AP-MS) has become a favorite method to study protein complexes. Here I
describe a procedure for single-step purification of ERK (Rolled) and associated proteins
from Drosophila cultured cells. The use of the streptavidin-binding peptide (SBP) tag
allows for a highly efficient isolation of native ERK signaling complexes, which are
suitable for subsequent analysis by mass spectrometry. Our analysis of the ERK
interactome has identified both known and novel signaling components. This method can
be easily adapted for SBP-based purification of protein complexes in any expression
system.
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1. Introduction
Receptor tyrosine kinase (RTK)/extracellular signal-regulated kinase (ERK)
signaling controls many cellular processes, including proliferation, differentiation, and
apoptosis (Futran et al., 2015; Lemmon and Schlessinger, 2010). Dysregulation of this
pathway has been implicated in multiple human diseases, including cancer (Jindal et al.,
2015; Lemmon and Schlessinger, 2010; Newbern et al., 2008; Rauen, 2013; Rauen et al.,
2011; Tidyman and Rauen, 2009). The development of relevant therapies depends on the
knowledge of the structure and dynamics of the ERK signaling network. Genetic analysis
of the RTK/ERK pathway in Drosophila and other model systems identified its key
components, and subsequent biochemical studies revealed key protein-protein
associations, such as those involving the core Raf-MEKERK kinase cascade, as well as
scaffolding and adaptor proteins (Li, 2005; Shilo, 2014; Sopko and Perrimon, 2013).
However emerging evidence suggests that the ERK signaling network is complex and
includes dozens of substrates and additional regulatory molecules (Friedman et al., 2011;
von Kriegsheim et al., 2009). Affinity purification of protein complexes followed by
mass spectrometry-based identification of interacting components has emerged as a
powerful method to study signaling networks (Gavin et al., 2011; Veraksa, 2013).
Previously our lab applied tandem affinity (TAP) purification to isolate signaling
complexes in Drosophila, first using the original TAP tag (Rigaut et al., 1999; Veraksa et
al., 2005), and more recently using an improved version, the GS-TAP tag (Burckstummer
et al., 2006; Kyriakakis et al., 2008). Both of these methods are rather lengthy, as they
require two affinity binding steps separated by tobacco etch virus (TEV) protease
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cleavage after the first affinity column. Due to inevitable sample loss at every step, they
require a large amount of starting material. In order to overcome these limitations, I have
developed and present here an efficient single-step purification approach for isolating
signaling complexes from Drosophila cultured cells, based on the use of streptavidinbinding peptide (SBP). SBP is a 38-amino acid peptide that was artificially selected for
high-affinity binding to native streptavidin (Keefe et al., 2001). Compared to other
affinity purification methods, the SBP tag offers several advantages. First, the SBP tag is
relatively compact and therefore less likely to impair protein function (4 kDa vs. 20 kDa
for the TAP or GS-TAP tags). Second, SBP interacts with native streptavidin with high
affinity (Kd = 2.5 nM), which results in an efficient association of the tagged protein with
the matrix (Keefe et al., 2001). Third, the SBP tag works well when placed either at the
amino or carboxy terminus of the protein, or even in the middle. Fourth, SBP-tagged
proteins can be eluted with a heterologous compound, biotin, which results in a lower
carryover of contaminants compared to other elution methods, such as competition with
excess tag peptide. Fifth, streptavidin matrices are less costly than many other affinity
resins.
Finally, single-step purification is faster and less labor-intensive than TAP. These
properties make SBP tagging an attractive option for affinity purification studies.
Usability of this approach has been validated in our studies involving various signaling
proteins (Degoutin et al., 2013; Dent et al., 2014; Gilbert et al., 2011; Zhang et al., 2015),
and this method has also been used to purify complexes from vertebrate cultured cells
(Kim et al., 2010a). In this section I describe a procedure to generate Drosophila cultured
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cells stably expressing SBP-tagged ERK, followed by purification of ERK protein
complexes. The mass spectrometry step is not presented, however I give suggestions for
preparing samples for this analysis and for analyzing mass spectrometry data using the
SAINT (significance analysis of interactome) program (Choi et al., 2011). Using this
workflow, I was able to identify most of the known core components of ERK signaling,
including two major ERK phosphatases. In addition, the identified list of ERK interactors
includes several proteins that have not been previously associated with ERK signaling.
Though the method I describe is for Drosophila cultured cells, it can be easily adapted for
mammalian cells or any other cell culture system.

2. Materials
A tissue culture facility and a general molecular biology lab with -20°C and -80°C
freezers and a 4°C cold room or a refrigeration chamber are needed for carrying out this
protocol. Prepare all solutions using ultrapure (18.2 MΩ·cm) water.

2.1. Tissue culture and cell transfection materials and reagents
1. Tissue culture hood with vacuum connection. Cell transfections are performed in the
hood.
2. Cell culture incubator at 25°C. Use a dish with ultrapure water at the bottom shelf to
maintain humidity in the incubator.
3. Qiagen Maxiprep plasmid purification kit.
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4. Qiagen Effectene transfection reagent.
5. Drosophila S2 cells (see Note 1).
6. Tissue culture treated sterile 6-well plates, e.g. Corning catalog number 3516.
7. Tissue culture treated vented 25 cm2 and 75 cm2 flasks, e.g. Corning catalog number
353109.
8. 15-mL and 50-mL Falcon tubes, sterile and regular Eppendorf tubes.
9. 250-mL and 500-mL sterile disposable filter units for preparing S2 cell media, 0.2 μm
pore size.
10. Clinical centrifuge that accommodates 15-mL and 50-mL Falcon tubes, at 4°C.
11. Microcentrifuge, at 4°C.
12. Vortex mixer in or next to the tissue culture hood.
13. Gibco Schneider’s Drosophila Medium (1x) with L-glutamine (Life Technologies
catalog number 21720024). Store at 4°C.
14. Gibco Fetal Bovine Serum (FBS), heat-inactivated (Life Technologies catalog
number
10082147). Aliquot by 50 mL in 50-mL Falcon tubes, store at -20°C.
15. Gibco Penicillin-Streptomycin, “Pen/Strep” (5,000 U/mL) (Life Technologies catalog
number 15070063). Aliquot by 5 mL in 15-mL Falcon tubes, store at -20°C.
16. Complete S2 cell medium: in the tissue culture hood, combine in a 500-mL filter unit:
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500 mL Schneider’s Drosophila Medium, 50 mL FBS, and 5 mL Pen/Strep, filter using
vacuum connection, cap and swirl to mix. Store at 4°C. Warm to room temperature
before use.
17. Hygromycin, 300 mg/mL stock solution: dissolve 250 mg hygromycin (Sigma
catalog number H3274) in 800 μL sterile PBS or ultrapure water, store at 4°C in the dark.
18. Complete S2 cell medium with 300 μg/mL hygromycin: co-filter 250 mL complete
S2 cell medium (item 16) with 250 μL hygromycin stock solution (1:1,000 dilution).
Wrap medium with hygromycin with aluminum foil to protect from light and store at 4°C
for up to 1 month. A larger (500 mL) batch can be made as needed.
19. Anti-SBP antibody: Santa Cruz Biotechnology sc-101595, anti-SBP Tag (clone
SB19-C4). Use 1:1000 for western blotting to check the expression of SBP-tagged
proteins.

2.2. Affinity purification reagents
1. 0.07 M CuSO4: dissolve 8.74 g CuSO4·5H2O in 500 mL water, filter-sterilize, store at
room temperature.
2. 1x phosphate buffer saline (PBS). Store at 4°C.
3. 5x lysis buffer: 250 mM Tris pH 7.5, 25% glycerol, 1% IGEPAL, 7.5 mM MgCl2, 625
Mm NaCl, 125 mM NaF, 5 mM Na3VO4. To make 200 mL: completely dissolve 1 g NaF
powder and 184 mg Na3VO4 powder in 71 ml water with constant stirring. Add 50 mL 1
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M Tris pH 7.5, 2 mL 100% IGEPAL (Sigma catalog number I8896), 1.5 mL 1 M MgCl2,
25 mL 5 M NaCl, then add 50 mL glycerol (add last) and continue stirring for one hour.
Filter-sterilize using 250-mL filter unit (this step can be slow). Aliquot by 10 mL in 50mL Falcon tubes and store at -80°C.
4. 1 M dithiothreitol (DTT) solution. Store at -20°C.
5. cOmplete™ protease inhibitor cocktail tablets, with EDTA: Roche catalog number
11697498001 (20 tablets). Store at 4°C.
6. Streptavidin beads: Pierce™ Streptavidin Plus UltraLink™ Resin, Pierce catalog
number 53117.
7. 10-ml Luer-Lok disposable syringes.
8. Syringe filters, 26 mm diameter, SFCA membrane, 0.45 μm pore size, e.g. Corning
catalog number 431220.
9. Dry heating block at 95°C.
10. 4x SDS sample buffer: 8% SDS, 160 mM Tris pH 6.8, 30% glycerol, 1 mg/ml
bromophenol blue. To make 100 mL; combine 50 mL water, 8 g SDS powder, 16 mL 1
M Tris pH 6.8, 30 mL glycerol, 100 mg bromophenol blue powder. Dissolve well with
constant stirring, filter-sterilize and store at room temperature. Before use, mix 950 μL
buffer with 50 μL 1 M DTT (to get 50 mM final DTT concentration), vortex to mix.
Buffer with DTT is stored at -20°C.
11. 2x SDS sample buffer: mix equal volumes of 4x SDS sample buffer (with DTT) and
water.
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12. Rotating wheel with clamps for Falcon tubes and Eppendorf tubes, at 4°C.
13. 200 mM biotin stock solution: in the chemical hood, mix 875 μL water with 125 μL
NH4OH (ammonium hydroxide solution, 28% NH3 in water), this will make 2 M NH4OH
solution. To this solution, add 50 mg biotin (e.g. Sigma catalog number B4501) and
vortex well. Store at -20°C.
14. 2 mM biotin working solution: dilute 200 mM biotin stock solution 1:100 with lysis
buffer with DTT and cOmplete™ protease inhibitor, see protocol step 3.2.2 (e.g. 990 μL
lysis buffer and 10 μL of 200 mM biotin stock). Make 2 mM biotin working solution
right before use and discard unused portion.
15. 100% (w/v) trichloroacetic acid (TCA) solution. To make 100% (w/v) TCA solution,
combine 500 g TCA crystals with 350 mL water, mix and store at room temperature.
16. 10% (w/v) TCA solution. Dilute 100% TCA 1:10 with water. Store at 4°C.
17. Acetone at -20°C.

2.3. Reagents for silver-staining gels
1. Molecular weight marker: any unstained marker can be used, but prefer BioRad
Precision Plus unstained standards. Dilute 1:10 with 2x SDS sample buffer. Store at 20°C.
2. Gel for silver staining: a regular SDS-PAGE can be used, however I find that
commercial gradient gels provide a better coverage of the complete molecular weight
range. I use Novex NuPAGE 4-12% Bis-Tris gels, 1.5 mm thick, with 10 wells, Life
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Technologies catalog number NP0335. They require a corresponding gel apparatus, such
as the XCell SureLock Mini system.
3. Electrophoresis buffer for NuPage Bis-Tris gels: MOPS SDS running buffer, with
antioxidant, Life Technologies catalog number NP0001.
4. Silver staining kit: Life Technologies SilverQuest Staining Kit, catalog number
LC6070.
5. Dish for silver staining.

3. Methods
3.1. Transfection and establishment of stable S2 cell lines
1. Clone your protein of interest into the pMK33-SBP-N or pMK33-SBP-C vector (Fig.
1A) (see Note 2). For this procedure, I used full-length Drosophila ERK (Rolled) cloned
into pMK33- SBP-C. Prepare DNA for transfection using Qiagen Maxiprep protocol
following manufacturer’s recommendations (see Note 3).
2. Dispense 1.5 mL per well of complete S2 cell medium in a 6-well plate. Add 0.5 mL of
Drosophila S2 cells from dense cultures (4-5 days). Incubate at 25°C overnight (optional)
or at least 3 hours to allow cell attachment to the bottom of the well.
3. Use Qiagen Effectene transfection reagent to prepare DNA for transfection into cells
(see Note 4). Perform all transfection steps in the hood. Mix in a sterile Eppendorf tube:
150 μL buffer EC, 2 μg DNA, 16 μL Enhancer, and vortex for 5 sec. Incubate at room
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Figure 1 Diagram of the pMK33-SBP vectors and workflow for single-step SBPbased purification. (A) Diagram of the pMK33-SBP vectors. Mt prom.:
metallothionein promoter for CuSO4-inducible expression; MCS: multiple cloning site
(polylinker). Unique cloning sites in the MCS are shown in bold and underlined. (B)
Workflow for single-step SBP-based purification, as described in the protocol.
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temperature for 5 min, briefly spin down. Add 21 μL Effectene reagent, immediately
vortex for exactly 10 sec, do not spin down. Incubate at room temperature for 15 min.
4. Remove old medium from cells using 1-mL tip. Add 1 mL of fresh complete medium
to cells, then add 1 mL of fresh complete medium to the tube with DNA from step 3,
gently but thoroughly pipet up and down 4-5 times, add DNA/medium solution dropwise
to cells, swirl to mix. Total volume will be 2 mL per well. Incubate plates with
transfected cells for 48 hours at 25°C.
5. Resuspend cells in the well, transfer to 15-mL Falcon tube, spin down for 3 min at 500
g in a clinical centrifuge, resuspend in 10 mL of complete medium with 300 μg/mL
hygromycin, and seed the cells in a 25 cm2 vented flask.
6. Carry out selection of stable cell lines. Watch the number of cells in the flasks and
allow them to reach good density before splitting. During the first 2-3 weeks, significant
cell death will be visible, and splitting can be done more rarely and retaining a higher
volume of cells (e.g. 1:1 split once a week instead of a normal 1:5 split every 4-5 days).
Medium should contain hygromycin during all passages. Cells in a control well (e.g.
transfected with actin-GFP) will completely die out after 3-4 weeks, and cells in the
experimental well should grow normally after about a month of continuous selection (see
Note 5).
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3.2. Cell lysis and affinity purification
A general workflow for affinity purification steps is shown in Fig. 1B. Unless
indicated otherwise, all cell collection, lysis and affinity purification steps should be
performed on ice (see Note 6).
1. Amplify cells in two 75 cm2 vented flasks, 25 mL in each flask, for a total of 50 mL
(see Note 7). Use untransfected S2 cells grown in parallel as a negative control sample
for purifications, and follow all of the same steps with that sample. Allow the cells to
grow to medium-high density (3-4 days) and induce overnight with 0.07 mM CuSO4 by
adding 25 μL of 0.07 M CuSO4 stock solution to 25 mL of cells in a flask (1:1000
dilution). Mix well by swirling and rocking the flask (see Note 8).
2. Prepare lysis buffer: add 40 mL water to 10 mL of 5x concentrated lysis buffer (stored
at - 80°C) in a 50-mL Falcon tube. Add 50 μL of 1 M DTT to a final concentration of 1
mM, mix well and separate into two 50-mL Falcon tubes, 25 mL in each. To one of the
tubes, add one cOmplete™ protease inhibitor tablet and rotate at 4°C for 30 min (see note
9). At the end, check to make sure the cOmplete™ tablet has fully dissolved. The second
tube can be stored at -80°C and will only require addition of the cOmplete™ tablet before
the next experiment. 25 mL of lysis buffer is sufficient for up to 4 purification samples.
3. While cOmplete™ tablet is dissolving, resuspend cells in flasks with a 10-mL pipette
and collect into a 50 mL Falcon tube on ice.
4. Spin in a clinical centrifuge at 500 g for 3 minutes at 4°C.
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5. Remove supernatant by aspiration and wash cells with 50 mL of cold PBS. Mix by
inversion.
6. Spin in a clinical centrifuge at 500 g for 5 minutes at 4°C. Remove as much
supernatant as possible.
7. Lysis: add 1 mL of cold lysis buffer with cOmplete™ protease inhibitor (from step 2)
to cells and pipet up and down 4-5 times to lyse the cells. For more efficient lysis, press
the tip against the bottom of the tube to create shearing force. Transfer lysate to a chilled
Eppendorf tube and incubate on ice for 15-20 minutes.
8. Prepare streptavidin beads, aiming for 50 μL of packed beads per sample. Take the
appropriate amount of 50% bead slurry and add to an Eppendorf tube. Wash beads three
times with 1 mL of lysis buffer (see step 2), mixing by inversion. After each wash,
centrifuge the tube for 1 min at 500 g at 4 °C. After the last wash, remove supernatant,
leaving the volume that is equal to the volume of packed beads (to obtain 50% slurry
after subsequent mixing). Keep washed beads on ice.
9. Centrifuge cell lysates from step 7 at maximum speed (e.g. 14,000 g) at 4°C for 15
min.
10. This step is best performed in the cold room. Aspirate supernatants with 1-ml tip and
load into chilled 10-ml syringes with 0.45 μm filters attached. Push all of the solution
into fresh Eppendorf tubes on ice. Optional: save Before Binding (BB) analytical sample:
mix 50 μL of lysate with 25 μL of 4x SDS sample buffer (see Note 10). Vortex and heat
at 95°C for 5 minutes. Store at -20°C.
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11. Binding: resuspend washed streptavidin beads by pipetting and add 100 μL of slurry
(corresponding to 50 μL of packed beads) to each sample (see Note 11). Rotate for 2-3
hours at 4°C on a rotating wheel.
12. Remove the tubes from the rotating wheel and centrifuge at 500 g for 1 min at 4 °C.
Optional: save the Flow-through (FT) analytical sample: mix 50 μL of supernatant with
25 μL of 4x SDS sample buffer. Vortex and heat at 95°C for 5 minutes. Store at -20 °C.
Aspirate and discard the rest of the supernatants, keeping the bead pellets.
13. Washes: add 1 mL of lysis buffer (see step 2) to the beads, mix by inversion 4-5 times
and spin down at 500 g for 1 min at 4°C. Aspirate and discard the supernatant.
14. Repeat step 13 four more times for a total of 5 washes. After the last wash, take care
to remove as much supernatant as possible, without dislodging the beads.
15. Elution: prepare 2 mM biotin working solution, 300 μL per sample, right before use,
by diluting 200 mM biotin stock solution 1:10 with lysis buffer. Resuspend bead samples
in 100 μL of 2 mM biotin working solution. Use a pipet tip with a large orifice to
resuspend the beads gently but completely by pipetting. Incubate on ice for 5 min.
Centrifuge at 500 g for 1 min at 4°C. Carefully collect 100 μL of supernatant, avoiding
the beads, and place in a new Eppendorf tube on ice.
16. Repeat step 15 two more times, each time adding 100 μL of the supernatant to the
same Eppendorf tube on ice, for a total of 300 μL of eluate after 3 elution steps. Optional:
collect the Retentate (RT) sample: place the tubes with the beads into a rack at room
temperature and let stand for 2 min. Add 50 μL of 4x SDS sample buffer to the beads,
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mix by swirling with a tip without pipetting, heat at 95 °C for 5 min and store at -20°C
(see Note 12).
17. Spin down pooled eluate at full speed for 30 sec at 4°C and transfer supernatant into a
fresh Eppendorf tube, avoiding any beads that may remain at the bottom. Optional:
collect the Eluate (EL) sample: combine 10 μL of eluate with 10 μL of 4x SDS sample
buffer. Mix by flicking, heat at 95 °C for 5 min and store at -20°C.
18. TCA precipitation: the final eluate will be divided into two unequal parts to prepare
samples for mass spectrometry and silver-stained gel analysis (see Fig. 1B). For the mass
spectrometry sample, combine 180 μL of eluate with 20 μL of 100% TCA in a fresh
Eppendorf tube labeled “MS.” For the silver-stained gel sample, combine 90 μL of eluate
with 10 μL of 100% TCA in a fresh Eppendorf tube labeled “SSG.” Mix well and
incubate on ice for 1 hr.
19. Centrifuge samples at maximum speed for 15 min at 4°C.
20. TCA wash: remove supernatant, add 500 μL of 10% TCA, mix by inversion, and
centrifuge samples at maximum speed for 15 min at 4°C.
21. Acetone washes: remove TCA wash and add 500 μL of cold acetone. Mix by
inversion. Centrifuge samples at maximum speed for 5 min at 4°C.
22. Remove supernatant and repeat acetone washes (step 21) three more times for a total
of 4 washes. After the last wash, remove supernatant as completely as possible and allow
the pellets to dry overnight in open tubes at room temperature. Loosely cover the rack
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with the tubes with aluminum foil to prevent dust from falling into tubes. Store dried
samples at -20°C until ready to analyze by gel electrophoresis.

3.3. Silver-stained gel
1. Prepare samples for analysis on a silver-stained gel. To the SSG dried pellet from step
3.2.18, add 20 μL of 2x SDS sample buffer and let stand at room temperature for 15 min,
flicking the tube periodically. Heat at 95°C for 5 min.
2. Run the samples using your choice of SDS-PAGE setup. I have successfully used
Novex NuPAGE 4-12% Bis-Tris gradient gels run with MOPS running buffer, as they
offer excellent separation of most molecular weights. Other brands can be used for this
purpose.
3. After the dye front reaches the bottom of the gel, open the cassette and place the gel in
a staining dish. Perform silver staining of the gel using the SilverQuest Staining Kit
following the Basic Staining Protocol, per manufacturer’s instructions.
4. Capture the image of the stained gel using a scanner or another imaging device. An
example of a silver-stained gel after ERK-SBP purification is shown in Fig. 2A (see Note
13).

3.4. Suggestions for preparation of samples for mass spectrometry and analysis of
interacting proteins
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Figure 2. Results of ERK-SBP purification from Drosophila S2 cells. (A) Silverstained gel showing a typical result from SBP-based purifications. Arrow indicates
position of the bait ERK-SBP protein. (B) Top portion of SAINT output. Proteins are
sorted according to the average probability of interaction, AvgP (column K). (C) The
ERK protein interactome in Drosophila S2 cells. The proteins shown were identified
with the SAINT score of >0.6, and were grouped into functional classes.
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After obtaining the final dried pellets of purified protein complexes, samples can
be analyzed by a variety of methods, including mass spectrometry (MS). Generally, the
user is advised to follow recommendations of their mass spectrometry facility of choice.
Dried pellets can be used directly for trypsin digestion and liquid chromatography tandem
mass spectrometry (nanoLC-MS/MS) analysis. In that case, care should be taken to
purify the peptides away from biotin and detergent. I found that separating the samples
on a short SDS-PAGE gel prior to submission for MS analysis improves protein
identification. The dye front is allowed to migrate in the separating gel up to a distance of
1 cm, then the gel is stained using a standard Coomassie dye/methanol/acetic acid
procedure, destained with 25% methanol/5% acetic acid and extensively washed in water,
after which the lane is cut into two square 5 mm x 5 mm pieces which are submitted for
MS analysis.
MS results can be analyzed in various ways. When applied to studying proteinprotein interactions, often a goal is to identify genuine interacting components and
eliminate contaminants. I found that one reliable and unbiased way to do it is using the
program SAINT (significance analysis of interactome) (Choi et al., 2011). Our lab and
others have validated SAINT in studies of various signaling complexes (Dent et al., 2014;
Kwon et al., 2013). The user is advised to follow the procedure described in the original
SAINT publication (Choi et al., 2011). I use the number of unique peptides identified for
each protein in a given purification dataset as input values, and run SAINT using
defaults. The most reliable results are obtained when two or more experimental
purifications are compared to two or more controls, preferably (but not critically) run in
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parallel with experimental samples. A higher number of controls further increases the
reliability of identifying genuine interactions.
Using this approach, I analyzed data from two independent ERK-SBP
purifications from Drosophila S2 cells and compared them to 5 control samples obtained
from untransfected S2 cells. The top portion of the SAINT output for these experiments
is shown in Fig. 2B. A key value to consider for evaluating protein interactions returned
by SAINT is AvgP, which is an average probability of interaction for every identified
protein (Fig. 2B). AvgP values above 0.8 are considered significant (Choi et al., 2011),
however relevant proteins may be identified even with lower values. Using SAINT cutoff
of 0.6, I was able to identify most of the known components of ERK signaling in our
studies (such as the core kinases Phl (Raf) and Dsor1 (MEK) (6), scaffolds and adaptors
Sos, Ksr, and Cnk (5), phosphatases Mkp3 and PTP-ER (Rintelen et al., 2003), and a
transcriptional repressor Cic (Jimenez et al., 2012), as well as several novel putative ERK
interactors (Fig. 2C).

4. Notes
1. There are different “flavors” of S2 cells grown in various laboratories. Our lab
obtained our S2 cells from Dr. S. Artavanis-Tsakonas (Harvard medical school). Once a
given line is selected for work, it should be consistently used for both control and
experimental samples.
2. Our lab has developed these vectors based on our previously published pMK33-NTAP
(GS) and pMK33-CTAP (SG) vectors (15). pMK33-based vectors allow for inducible
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expression of a gene of interest using induction with CuSO4, and facilitate establishment
of stable cell lines using hygromycin selection, because hygromycin resistance gene is
carried in the same construct. These vectors are medium-copy plasmids.
3. I have found that a final phenol/chloroform extraction of plasmid DNA after Qiagen
Maxiprep followed by precipitation with sodium acetate/ethanol further improves
transfection efficiency.
4. Qiagen Effectene transfection reagent does not require incubation of either cells or
DNA in serum-free media. It is always good to include a separate transfection control
performed in parallel to the main experiment, e.g. a plasmid encoding actin-GFP. This
way general success of transfection can be verified by assessing the number of GFPpositive cells in a small aliquot from that well, and also the same well can be used to
verify successful selection using hygromycin, as control cells that do not have the
pMK33 plasmid should all die during selection.
5. After establishment of a stable cell line, expression of the tagged protein can be
verified after an overnight induction with 0.35 mM CuSO4 followed by cell lysis and
western blotting using anti-SBP antibody.
6. For holding Eppendorf tubes during the washes and solution changes, I use an
aluminum block that is embedded in ice (e.g. from a dry bath). This makes it convenient
to perform tube inversions by removing the whole block with the tubes, rather than doing
it one by one for each tube, and keeps the samples at 0°C at all times. Care should be
taken to make sure that the ice is well packed around the block and there is little water in
the ice bucket, otherwise the block may sink.
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7. While hygromycin-containing medium should be used for maintaining the main cell
line at all times, hygromycin can be omitted from the medium for final cell amplification
step, which can reduce the cost.
8. This concentration of CuSO4 will result in a medium level of protein induction. This is
recommended to avoid possible artefacts resulting from extreme overexpression of the
tagged protein.
9. I am using 2x recommended concentration of cOmplete™ protease inhibitor for a
stronger inhibition of proteases. Remaining buffer with cOmplete™ protease inhibitor
can be stored in 1- mL single-use aliquots at -80°C.
10. Analytical samples can be collected throughout the procedure where indicated. These
fractions can be analyzed by western blotting with anti-SBP antibody using
approximately 10 μL from each of the collected samples.
11. Cut off the tip to obtain a larger orifice for bead resuspension.
12. The Retentate (RT) sample may contain a lot of protein, so further dilution (e.g. 1:5
with 2x SDS buffer) is recommended for western blot analysis.
13. Silver staining is used for a sensitive quality assessment of the sample. Some proteins
may be visible in a control sample from untransfected S2 cells. The major band in the
experimental lane will be the SBP-tagged bait protein, which should migrate at the
expected molecular weight (taking into account 4 kDa added by the SBP tag). Additional
bands of interacting proteins should be visible in the experimental lane.
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